| Year |
Citation |
Score |
| 2023 |
Gao X, Wang X, Guan Y, Wang L, Gao Y, Niu J. Soluble immune checkpoints are elevated in patients with primary biliary cholangitis. European Journal of Medical Research. 28: 477. PMID 37915081 DOI: 10.1186/s40001-023-01419-6 |
0.445 |
|
| 2023 |
Zi J, Li YH, Wang XM, Xu HQ, Liu WH, Cui JY, Niu JQ, Chi XM. Hepatitis D virus dual-infection among Chinese hepatitis B patient related to hepatitis B surface antigen, hepatitis B virus DNA and age. World Journal of Gastroenterology. 29: 5395-5405. PMID 37900584 DOI: 10.3748/wjg.v29.i38.5395 |
0.567 |
|
| 2023 |
Hua R, Kong F, Li G, Wen X, Zhang Y, Yang X, Meng C, Xie W, Jiang Y, Wang X, Han X, Huang Y, Mao Q, Wang J, Guan Y, ... ... Niu J, et al. Alfosbuvir plus Daclatasvir for Treatment of Chronic Hepatitis C Virus Infection in China. Infectious Diseases and Therapy. PMID 37856013 DOI: 10.1007/s40121-023-00872-4 |
0.563 |
|
| 2023 |
Hu Y, Li H, Zhang H, Chen X, Chen J, Xu Z, You H, Dong R, Peng Y, Li J, Li X, Wu D, Zhang L, Cao D, Jin H, ... ... Niu J, et al. ZSP1601, a novel pan-phosphodiesterase inhibitor for the treatment of NAFLD, A randomized, placebo-controlled phase Ib/IIa trial. Nature Communications. 14: 6409. PMID 37828034 DOI: 10.1038/s41467-023-42162-0 |
0.461 |
|
| 2023 |
Wang Z, Solanki MK, Kumar A, Solanki AC, Pang F, Ba ZX, Niu JQ, Ren ZX. Promoting plant resilience against stress by engineering root microenvironment with Streptomyces inoculants. Microbiological Research. 277: 127509. PMID 37788547 DOI: 10.1016/j.micres.2023.127509 |
0.368 |
|
| 2023 |
Li Y, Yang Y, Li T, Wang Z, Gao C, Deng R, Ma F, Li X, Ma L, Tian R, Li H, Zhu H, Zeng L, Gao Y, Lv G, ... Niu J, et al. Activation of AIM2 by hepatitis B virus results in antiviral immunity that suppresses hepatitis C virus during coinfection. Journal of Virology. e0109023. PMID 37787533 DOI: 10.1128/jvi.01090-23 |
0.587 |
|
| 2023 |
Zhao Y, Sui L, Wu P, Li L, Liu L, Ma B, Wang W, Chi H, Wang ZD, Wei Z, Hou Z, Zhang K, Niu J, Jin N, Li C, et al. EGR1 functions as a new host restriction factor for SARS-CoV-2 to inhibit virus replication through the E3 ubiquitin ligase MARCH8. Journal of Virology. e0102823. PMID 37772822 DOI: 10.1128/jvi.01028-23 |
0.441 |
|
| 2023 |
He H, Wu Y, Jia Z, Xu H, Pan Y, Cao D, Zhang Y, Tao X, Zhao T, Lv H, Yi J, Wang Y, Gao Y, Kou C, Niu J, et al. Risk-stratified approach by aMAP score for community population infected with hepatitis B and C to guide subsequent liver cancer screening practice: A cohort study with 10-year follow-up. Journal of Viral Hepatitis. PMID 37723945 DOI: 10.1111/jvh.13884 |
0.433 |
|
| 2023 |
Gao X, Ma H, Niu J, Li D. FcγRIIB expression increases during primary biliary cholangitis. Molecular Immunology. 162: 30-37. PMID 37634276 DOI: 10.1016/j.molimm.2023.08.001 |
0.472 |
|
| 2023 |
Fan R, Chen L, Zhao S, Yang H, Li Z, Qian Y, Ma H, Liu X, Wang C, Liang X, Bai J, Xie J, Fan X, Xie Q, Hao X, ... ... Niu J, et al. Novel, high accuracy models for hepatocellular carcinoma prediction based on longitudinal data and cell-free DNA signatures. Journal of Hepatology. PMID 37302583 DOI: 10.1016/j.jhep.2023.05.039 |
0.435 |
|
| 2023 |
Wong YJ, Tran S, Huang CF, Hsu YC, Preda C, Toyoda H, Liu J, Jun DW, Landis C, Huang DQ, Gila A, Negoita L, Yasuda S, Tseng CH, Tsai PC, ... ... Niu J, et al. Real-world treatment outcome with protease inhibitor direct-acting antiviral in advanced hepatitis C cirrhosis: a REAL-C study. Hepatology International. PMID 37273170 DOI: 10.1007/s12072-023-10547-4 |
0.513 |
|
| 2023 |
Dong Y, Liu Y, Liu X, Ma H, Liu Y, Lv G, Niu J. Multi-omics profiling of primary hepatic stellate cells from advanced liver fibrosis patients reveals distinctive molecular signatures. Journal of Gastroenterology and Hepatology. PMID 37226284 DOI: 10.1111/jgh.16221 |
0.542 |
|
| 2023 |
Li L, Yang X, Ji W, Zhu Q, Yang X, Niu J, Li W. Emphasis on the clinical relationship between alpha-fetoprotein and hepatoid adenocarcinoma of the stomach: a retrospective study. Bmc Gastroenterology. 23: 142. PMID 37161409 DOI: 10.1186/s12876-023-02773-9 |
0.389 |
|
| 2023 |
Jia H, Mai J, Wu M, Chen H, Li X, Li C, Liu J, Liu C, Hu Y, Zhu X, Jiang X, Hua B, Xia T, Liu G, Deng A, ... ... Niu J, et al. Safety, tolerability, pharmacokinetics, and antiviral activity of the novel core protein allosteric modulator ZM-H1505R (Canocapavir) in chronic hepatitis B patients: a randomized multiple-dose escalation trial. Bmc Medicine. 21: 98. PMID 36927420 DOI: 10.1186/s12916-023-02814-w |
0.571 |
|
| 2023 |
Wu LS, Hu Y, Gane EJ, Slaets L, De Creus A, Ding Y, Niu J, Schwabe C, Goeyvaerts N, Xu Z, Huo D, Tuefferd M, Verbrugge I, Van Remoortere P, Schwertschlag U, et al. Population pharmacokinetic/pharmacodynamic models of JNJ-64794964, a toll-like receptor 7 agonist, in healthy adult participants. Antiviral Therapy. 28: 13596535231151626. PMID 36691849 DOI: 10.1177/13596535231151626 |
0.511 |
|
| 2023 |
Tang Y, Fan R, Lan Z, Xie Q, Zhang J, Liang X, Wang H, Tan D, Cheng J, Chen S, Ning Q, Bai X, Xu M, Chen X, Niu J, et al. Impact of nonalcoholic fatty liver disease status change on antiviral efficacy of nucleos(t)ide analogues in HBeAg-positive chronic hepatitis B. Journal of Medical Virology. PMID 36655747 DOI: 10.1002/jmv.28501 |
0.538 |
|
| 2022 |
Liu Z, Jin Q, Zhang Y, Gong G, Wu G, Yao L, Wen X, Gao Z, Huang Y, Yang D, Chen E, Mao Q, Lin S, Shang J, Gong H, ... ... Niu J, et al. 96-Week Treatment of Tenofovir Amibufenamide and Tenofovir Disoproxil Fumarate in Chronic Hepatitis B Patients. Journal of Clinical and Translational Hepatology. 11: 649-660. PMID 36969889 DOI: 10.14218/JCTH.2022.00058 |
0.482 |
|
| 2022 |
Pang F, Niu J, Solanki MK, Nosheen S, Liu Z, Wang Z. family genes in wheat ( L.): Evolutionary conservatism, functional diversification, and active expression in abiotic stress. Frontiers in Plant Science. 13: 1016831. PMID 36578331 DOI: 10.3389/fpls.2022.1016831 |
0.381 |
|
| 2022 |
Liu X, Ma H, Wu R, Wang H, Xu H, Li S, Wang G, Lv G, Niu J. Identification of Liver Fibrosis-Related MicroRNAs in Human Primary Hepatic Stellate Cells Using High-Throughput Sequencing. Genes. 13. PMID 36553468 DOI: 10.3390/genes13122201 |
0.434 |
|
| 2022 |
Liu Y, Xu H, Zhao Z, Dong Y, Wang X, Niu J. No evidence for a causal link between infection and nonalcoholic fatty liver disease: A bidirectional Mendelian randomization study. Frontiers in Microbiology. 13: 1018322. PMID 36406444 DOI: 10.3389/fmicb.2022.1018322 |
0.462 |
|
| 2022 |
Xu H, Li H, You H, Zhang P, Li N, Jiang N, Cao Y, Qin L, Qin G, Qu H, Wang H, Zou B, He X, Li D, Zhao H, ... ... Niu J, et al. Effectiveness of inactivated COVID-19 vaccines against mild disease, pneumonia, and severe disease among persons infected with SARS-CoV-2 Omicron variant: Real-world study in Jilin Province, China. Emerging Microbes & Infections. 1-30. PMID 36398721 DOI: 10.1080/22221751.2022.2149935 |
0.403 |
|
| 2022 |
Shi Y, Yang X, Wang S, Wu Y, Zheng L, Tang Y, Gao Y, Niu J. Human umbilical cord mesenchymal stromal cell-derived exosomes protect against MCD-induced NASH in a mouse model. Stem Cell Research & Therapy. 13: 517. PMID 36371344 DOI: 10.1186/s13287-022-03201-7 |
0.402 |
|
| 2022 |
Ma ZH, Wang XM, Wu RH, Hao DL, Sun LC, Li P, Niu JQ. Serum metabolic profiling of targeted bile acids reveals potentially novel biomarkers for primary biliary cholangitis and autoimmune hepatitis. World Journal of Gastroenterology. 28: 5764-5783. PMID 36338890 DOI: 10.3748/wjg.v28.i39.5764 |
0.503 |
|
| 2022 |
Yue Y, Nan J, Che Y, Xu H, Sun W, Zhang F, Wang L, Xu W, Niu J, Zhu S, Zhang J, Yang B. Thermal-annealing-regulated plasmonic enhanced fluorescence platform enables accurate detection of antigen/antibody against infectious diseases. Nano Research. 1-9. PMID 36312893 DOI: 10.1007/s12274-022-5035-6 |
0.395 |
|
| 2022 |
Li H, Zhu M, Zhang P, Yan X, Niu J, Wang Z, Cao J. Milder symptoms and shorter course in patients with re-positive COVID-19: A cohort of 180 patients from Northeast China. Frontiers in Microbiology. 13: 989879. PMID 36304945 DOI: 10.3389/fmicb.2022.989879 |
0.435 |
|
| 2022 |
Wu X, Kang J, Liu Y, Sun G, Shi Y, Niu J. A rare hepatic artery variant reporting and a new classification. Frontiers in Surgery. 9: 1003350. PMID 36105121 DOI: 10.3389/fsurg.2022.1003350 |
0.469 |
|
| 2022 |
Liu Y, Dong Y, Wu X, Wang X, Niu J. Identification of Immune Microenvironment Changes and the Expression of Immune-Related Genes in Liver Cirrhosis. Frontiers in Immunology. 13: 918445. PMID 35903097 DOI: 10.3389/fimmu.2022.918445 |
0.464 |
|
| 2022 |
Wang C, Shi Y, Wang X, Ma H, Liu Q, Gao Y, Niu J. Peroxisome Proliferator-Activated Receptors Regulate Hepatic Immunity and Assist in the Treatment of Primary Biliary Cholangitis. Frontiers in Immunology. 13: 940688. PMID 35880178 DOI: 10.3389/fimmu.2022.940688 |
0.46 |
|
| 2022 |
Li H, Gao M, You H, Zhang P, Pan Y, Li N, Qin L, Wang H, Li D, Li Y, Qiao H, Gu L, Xu S, Guo W, Wang N, ... ... Niu J, et al. Association of nirmatrelvir/ritonavir treatment on upper respiratory SARS-CoV-2 RT-PCR negative conversion rates among high-risk patients with COVID-19. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 35870128 DOI: 10.1093/cid/ciac600 |
0.436 |
|
| 2022 |
Yang A, Zhu X, Zhang L, Zhang Y, Zhang D, Jin M, Niu J, Zhang H, Ding Y, Lv G. Non-invasive evaluation of NAFLD and the contribution of genes: an MRI-PDFF-based cross-sectional study. Hepatology International. PMID 35829866 DOI: 10.1007/s12072-022-10355-2 |
0.397 |
|
| 2022 |
Zhang M, Zhang H, Cheng X, Wang X, Xu H, Gao X, Wu R, Zhang D, Xia Y, Niu J. Liver biopsy of chronic hepatitis B patients indicates HBV integration profile may complicate the endpoint and effect of entecavir treatment. Antiviral Research. 105363. PMID 35709897 DOI: 10.1016/j.antiviral.2022.105363 |
0.553 |
|
| 2022 |
Wei Q, Song H, Gao Y, Xu F, Xiao Q, Wang F, Lei B, Niu J, Gao P, Ma H, Tan G. Dual-Role of Cholesterol-25-Hydroxylase in Regulating Hepatitis B Virus Infection and Replication. Mbio. e0067722. PMID 35587189 DOI: 10.1128/mbio.00677-22 |
0.554 |
|
| 2022 |
Liu Y, Dong Y, Wu X, Xu X, Niu J. The assessment of mesenchymal stem cells therapy in acute on chronic liver failure and chronic liver disease: a systematic review and meta-analysis of randomized controlled clinical trials. Stem Cell Research & Therapy. 13: 204. PMID 35578365 DOI: 10.1186/s13287-022-02882-4 |
0.485 |
|
| 2022 |
Wang X, Gao X, Wu R, Chi X, Xu H, Guan Y, Jin Q, Niu J. Serum qAnti-HBc combined with ALT and HBsAg predicts significant hepatic inflammation in HBeAg-positive immune active patients. Journal of Gastroenterology and Hepatology. PMID 35509262 DOI: 10.1111/jgh.15881 |
0.562 |
|
| 2022 |
Ma H, Wang X, Liu X, Wang C, Gao X, Niu J. miR-654-5p Contributes to the Activation and Proliferation of Hepatic Stellate Cells by Targeting RXRα. Frontiers in Cell and Developmental Biology. 10: 841248. PMID 35465330 DOI: 10.3389/fcell.2022.841248 |
0.408 |
|
| 2022 |
Zi J, Gao X, Du J, Xu H, Niu J, Chi X. Multiple Regions Drive Hepatitis Delta Virus Proliferation and Are Therapeutic Targets. Frontiers in Microbiology. 13: 838382. PMID 35464929 DOI: 10.3389/fmicb.2022.838382 |
0.556 |
|
| 2022 |
Li X, Liu Y, Yao H, Wang M, Gao L, Lou J, Mao J, Wu W, Zhou Y, Tang Y, Yan W, Hu Y, Ding C, Chen S, Niu J, et al. Safety, Tolerability, and Pharmacokinetics of the Novel Hepatitis B Virus Expression Inhibitor GST-HG131 in Healthy Chinese Subjects: a First-in-Human Single- and Multiple-Dose Escalation Trial. Antimicrobial Agents and Chemotherapy. e0009422. PMID 35404074 DOI: 10.1128/aac.00094-22 |
0.417 |
|
| 2022 |
Zhou H, Wang X, Steer CJ, Song G, Niu J. Efficient silencing of hepatitis B virus S gene through CRISPR-mediated base editing. Hepatology Communications. PMID 35338607 DOI: 10.1002/hep4.1933 |
0.532 |
|
| 2022 |
Hua R, Kong F, Wen X, Xiong Q, Chen J, Meng C, Ma H, Tan Y, Huang Y, Jiang Y, Guan Y, Mao X, Wang J, Xin Y, Gao H, ... ... Niu J, et al. Efficacy and safety of alfosbuvir plus daclatasvir in Chinese patients with hepatitis C virus genotypes 1, 2, 3, and 6 infection - an open-label, phase 2 study. Journal of Viral Hepatitis. PMID 35080256 DOI: 10.1111/jvh.13650 |
0.557 |
|
| 2022 |
Yuan HF, Zhao M, Zhao LN, Yun HL, Yang G, Geng Y, Wang YF, Zheng W, Yuan Y, Song TQ, Niu JQ, Zhang XD. PRMT5 confers lipid metabolism reprogramming, tumour growth and metastasis depending on the SIRT7-mediated desuccinylation of PRMT5 K387 in tumours. Acta Pharmacologica Sinica. PMID 35046516 DOI: 10.1038/s41401-021-00841-y |
0.381 |
|
| 2022 |
Liu Z, Liu Z, Xiao L, Niu J, Hou J. Editorial: the three tenors in HBV-TDF, TAF and now TMF. Authors' reply. Alimentary Pharmacology & Therapeutics. 55: 121. PMID 34907550 DOI: 10.1111/apt.16692 |
0.492 |
|
| 2021 |
Miao XR, Chen QX, Niu JQ, Guo YP. The complete chloroplast genome of highbush blueberry (). Mitochondrial Dna. Part B, Resources. 7: 87-88. PMID 34993320 DOI: 10.1080/23802359.2021.2009384 |
0.37 |
|
| 2021 |
Zhong X, Zhang S, Zhang Y, Jiang Z, Li Y, Chang J, Niu J, Shi Y. HMGB3 is Associated With an Unfavorable Prognosis of Neuroblastoma and Promotes Tumor Progression by Mediating TPX2. Frontiers in Cell and Developmental Biology. 9: 769547. PMID 34988076 DOI: 10.3389/fcell.2021.769547 |
0.414 |
|
| 2021 |
Li T, Yang Y, Li Y, Wang Z, Ma F, Luo R, Xu X, Zhou G, Wang J, Niu J, Lv G, Crispe IN, Tu Z. Platelets mediate inflammatory monocyte activation by SARS-CoV-2 Spike protein. The Journal of Clinical Investigation. PMID 34964720 DOI: 10.1172/JCI150101 |
0.411 |
|
| 2021 |
Ru L, Wang XM, Niu JQ. The miR-23-27-24 cluster: an emerging target in NAFLD pathogenesis. Acta Pharmacologica Sinica. 43: 1167-1179. PMID 34893685 DOI: 10.1038/s41401-021-00819-w |
0.42 |
|
| 2021 |
Zhi Y, Sun Y, Jiao Y, Pan C, Wu Z, Liu C, Su J, Zhou J, Shang D, Niu J, Hua R, Yin P. HR-MS Based Untargeted Lipidomics Reveals Characteristic Lipid Signatures of Wilson's Disease. Frontiers in Pharmacology. 12: 754185. PMID 34880754 DOI: 10.3389/fphar.2021.754185 |
0.395 |
|
| 2021 |
Jin J, Liu Y, Xu X, Wang Z, Niu J. The association between Fc gamma RIIb expression levels and chronic hepatitis B virus infection progression. Bmc Infectious Diseases. 21: 1235. PMID 34879827 DOI: 10.1186/s12879-021-06918-7 |
0.572 |
|
| 2021 |
Chi XM, Wang XM, Wang ZF, Wu RH, Gao XZ, Xu HQ, Ding YH, Niu JQ. Serum hepatitis B core-related antigen as a surrogate marker of hepatitis B e antigen seroconversion in chronic hepatitis B. World Journal of Gastroenterology. 27: 6927-6938. PMID 34790015 DOI: 10.3748/wjg.v27.i40.6927 |
0.553 |
|
| 2021 |
Wang C, Peng F, Zhong B, Shi Y, Wang X, Jin X, Niu J. Metabolomic Analysis Reveals the Therapeutic Effects of MBT1805, a Novel Pan-Peroxisome Proliferator-Activated Receptor Agonist, on α-Naphthylisothiocyanate-Induced Cholestasis in Mice. Frontiers in Pharmacology. 12: 732478. PMID 34776958 DOI: 10.3389/fphar.2021.732478 |
0.565 |
|
| 2021 |
Li Y, Shen S, Guo H, Zhang Z, Zhang L, Yang Q, Gao Y, Niu J, Wei W. Enterovirus Infection Restricts Long Interspersed Element 1 Retrotransposition. Frontiers in Microbiology. 12: 706241. PMID 34733242 DOI: 10.3389/fmicb.2021.706241 |
0.398 |
|
| 2021 |
Liu Z, Jin Q, Zhang Y, Gong G, Wu G, Yao L, Wen X, Gao Z, Huang Y, Yang D, Chen E, Mao Q, Lin S, Shang J, Gong H, ... ... Niu J, et al. Randomised clinical trial: 48 weeks of treatment with tenofovir amibufenamide versus tenofovir disoproxil fumarate for patients with chronic hepatitis B. Alimentary Pharmacology & Therapeutics. PMID 34587302 DOI: 10.1111/apt.16611 |
0.514 |
|
| 2021 |
Roggenbach I, Chi X, Lempp FA, Qu B, Walter L, Wu R, Gao X, Schnitzler P, Ding Y, Urban S, Niu J. HDV Seroprevalence in HBsAg-Positive Patients in China Occurs in Hotspots and Is Not Associated with HCV Mono-Infection. Viruses. 13. PMID 34578380 DOI: 10.3390/v13091799 |
0.548 |
|
| 2021 |
Gao Y, Kong F, Song X, Shang J, Yao L, Xia J, Peng Y, Liu W, Gong H, Mu M, Cui H, Han T, Chen W, Wu X, Yang Y, ... ... Niu J, et al. Pradefovir Treatment in Patients with Chronic Hepatitis B: Week 24 Results from a Multicenter, Double-blind, Randomized, Noninferiority, Phase 2 Trial. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 34487151 DOI: 10.1093/cid/ciab763 |
0.508 |
|
| 2021 |
Peng G, Wang Y, Ge P, Bailey C, Zhang P, Zhang D, Meng Z, Qi C, Chen Q, Chen J, Niu J, Zheng P, Liu Y, Liu Y. The HIF1α-PDGFD-PDGFRα axis controls glioblastoma growth at normoxia/mild-hypoxia and confers sensitivity to targeted therapy by echinomycin. Journal of Experimental & Clinical Cancer Research : Cr. 40: 278. PMID 34470658 DOI: 10.1186/s13046-021-02082-7 |
0.378 |
|
| 2021 |
Wei L, Zhao T, Zhang J, Mao Q, Gong G, Sun Y, Chen Y, Wang M, Tan D, Gong Z, Li B, Niu J, Li S, Gong H, Zou L, et al. Efficacy and Safety of a Nanoparticle Therapeutic Vaccine in Patients with Chronic Hepatitis B: A Randomized Clinical Trial. Hepatology (Baltimore, Md.). PMID 34396571 DOI: 10.1002/hep.32109 |
0.5 |
|
| 2021 |
Zhang Z, Guo H, Wang J, Li Y, Gao Y, Liu Q, Niu J, Wei W. Inhibition of the Neddylation Pathway Suppresses Enterovirus Replication. Virologica Sinica. PMID 34351571 DOI: 10.1007/s12250-021-00427-2 |
0.386 |
|
| 2021 |
Li X, Hollingshead N, Lampert S, Truong CD, Li W, Niu J, Crispe IN, Soysa R. A conserved pathway of transdifferentiation in murine Kupffer cells. European Journal of Immunology. PMID 34324208 DOI: 10.1002/eji.202049124 |
0.463 |
|
| 2021 |
Li C, Wu M, Zhang H, Mai J, Yang L, Ding Y, Niu J, Mao J, Wu W, Zhang D, Tang Y, Yan W. Safety, tolerability, and pharmacokinetics of the novel hepatitis B virus capsid assembly modulator GST-HG141 in healthy Chinese subjects: a first-in-human single- and multiple-dose escalation trial. Antimicrobial Agents and Chemotherapy. AAC0122021. PMID 34280012 DOI: 10.1128/AAC.01220-21 |
0.49 |
|
| 2021 |
Li C, Xiang W, Wu M, Zhang H, Cheng J, Yang T, Mai J, Chi X, Gao X, Ding Y, Niu J. A Randomized Dose-Escalation Study on the Safety, Tolerability, Immunogenicity, Pharmacokinetics and Pharmacodynamics of a Novel Recombinant Human Albumin in Healthy Subjects. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 105923. PMID 34229078 DOI: 10.1016/j.ejps.2021.105923 |
0.411 |
|
| 2021 |
Fan R, Niu J, Ma H, Xie Q, Cheng J, Rao H, Dou X, Xie J, Zhao W, Peng J, Gao Z, Gao H, Chen X, Chen J, Li Q, et al. Association of central obesity with hepatocellular carcinoma in patients with chronic hepatitis B receiving antiviral therapy. Alimentary Pharmacology & Therapeutics. PMID 34157146 DOI: 10.1111/apt.16469 |
0.504 |
|
| 2021 |
Pang X, Huang K, Zhang Q, Zhang Y, Niu J. [Retracted] miR‑154 targeting ZEB2 in hepatocellular carcinoma functions as a potential tumor suppressor. Oncology Reports. 46. PMID 34132377 DOI: 10.3892/or.2021.8113 |
0.374 |
|
| 2021 |
Wang YC, Wei Z, Lv X, Han S, Wang Z, Fan C, Zhang X, Shao J, Zhao YH, Sui L, Chen C, Liao M, Wang B, Jin N, Li C, ... ... Niu J, et al. A new nairo-like virus associated with human febrile illness in China. Emerging Microbes & Infections. 1-51. PMID 34044749 DOI: 10.1080/22221751.2021.1936197 |
0.477 |
|
| 2021 |
Yang LL, Niu JQ, Tang WW. The complete chloroplast genome of pioneering plant L. (Cyperaceae) in ecological restoration. Mitochondrial Dna. Part B, Resources. 6: 1335-1336. PMID 33889743 DOI: 10.1080/23802359.2021.1908865 |
0.367 |
|
| 2021 |
Ma H, Liu X, Zhang M, Niu J. Liver sinusoidal endothelial cells are implicated in multiple fibrotic mechanisms. Molecular Biology Reports. PMID 33730288 DOI: 10.1007/s11033-021-06269-1 |
0.489 |
|
| 2021 |
Zhan MR, Gao XZ, Wang C, Peng F, Wang XM, Xu HQ, Niu JQ. Elevated soluble 4-1BB is associated with serum markers of hepatitis B virus in patients with chronic hepatitis B. World Journal of Clinical Cases. 9: 1619-1630. PMID 33728305 DOI: 10.12998/wjcc.v9.i7.1619 |
0.666 |
|
| 2021 |
Ma H, Wang C, Liu X, Zhan M, Wei W, Niu J. Src homolog and collagen homolog1 isoforms in acute and chronic liver injuries. Life Sciences. 119302. PMID 33662427 DOI: 10.1016/j.lfs.2021.119302 |
0.491 |
|
| 2021 |
Kong F, Wen X, Wen X, Wang X, Wu G, Lin S, Wang L, Xing H, Yan X, Zheng S, Ning Q, Wang Z, Zhang L, Lin J, Tong Z, ... ... Niu J, et al. Seraprevir and sofosbuvir for treatment of chronic hepatitis C virus infection: a single-arm, open-label, phase 3 trial. Journal of Gastroenterology and Hepatology. PMID 33491236 DOI: 10.1111/jgh.15412 |
0.548 |
|
| 2021 |
Wang X, Chi X, Wu R, Xu H, Gao X, Yu L, Liu L, Zhang M, Tan Y, Niu J, Jin Q. Serum HBV RNA correlated with intrahepatic cccDNA more strongly than other HBV markers during peg-interferon treatment. Virology Journal. 18: 4. PMID 33407619 DOI: 10.1186/s12985-020-01471-2 |
0.523 |
|
| 2021 |
Zhang H, Hu Y, Wu M, Liu J, Li X, Zhu X, Li C, Chen H, Liu C, Niu J, Ding Y. Safety, Pharmacokinetics, and Pharmacodynamics of TQ-A3334, an Oral Toll-Like Receptor 7 Agonist, in Healthy Individuals. Expert Opinion On Investigational Drugs. PMID 33405993 DOI: 10.1080/13543784.2021.1873275 |
0.429 |
|
| 2020 |
Zhang M, Zhang Y, Liu L, Prithweeraj M, Xu H, Wu R, Wen X, Niu J. Neutrophil-to-Lymphocyte Ratio and Albumin: New Serum Biomarkers to Predict the Prognosis of Male Alcoholic Cirrhosis Patients. Biomed Research International. 2020: 7268459. PMID 33415154 DOI: 10.1155/2020/7268459 |
0.436 |
|
| 2020 |
Gao X, Zhan M, Wang L, Ding Y, Niu J. Timing of DAA Initiation After Curative Treatment and Its Relationship with the Recurrence of HCV-Related HCC. Journal of Hepatocellular Carcinoma. 7: 347-360. PMID 33299823 DOI: 10.2147/JHC.S279657 |
0.525 |
|
| 2020 |
Zhang H, Hu Y, Wu M, Liu J, Zhu X, Li X, Chen H, Li C, Liu C, Niu J, Ding Y. Randomised clinical trial: safety, efficacy and pharmacokinetics of HS-10234 versus tenofovir for the treatment of chronic hepatitis B infection. Alimentary Pharmacology & Therapeutics. PMID 33249630 DOI: 10.1111/apt.16196 |
0.524 |
|
| 2020 |
Luo M, Gao L, Niu J, Chen C, Wang H, Chen Y. Liver failure in pregnancy: a review of 25 cases. Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology. 1-6. PMID 33241706 DOI: 10.1080/01443615.2020.1824214 |
0.463 |
|
| 2020 |
Tang J, Wang Y, Han T, Mao Q, Cheng J, Ding H, Shang J, Zhang Q, Niu J, Ji F, Chen C, Jia J, Jiang X, Lv N, Gao Y, et al. Tolvaptan therapy of Chinese cirrhotic patients with ascites after insufficient diuretic routine medication responses: a phase III clinical trial. Bmc Gastroenterology. 20: 391. PMID 33213378 DOI: 10.1186/s12876-020-01536-0 |
0.42 |
|
| 2020 |
Zhang H, Wu M, Zhu X, Li C, Li X, Sun J, Liu C, Liu Q, Wei W, Niu J, Ding Y. A Phase I, Randomized, Single-Dose Study to Evaluate the Biosimilarity of QL1206 to Denosumab Among Chinese Healthy Subjects. Frontiers in Pharmacology. 11: 01329. PMID 33132906 DOI: 10.3389/fphar.2020.01329 |
0.379 |
|
| 2020 |
Liu M, Wu R, Liu X, Xu H, Chi X, Wang X, Zhan M, Wang B, Peng F, Gao X, Shi Y, Wen X, Ji Y, Jin Q, Niu J. Validation of the GALAD Model and Establishment of GAAP Model for Diagnosis of Hepatocellular Carcinoma in Chinese Patients. Journal of Hepatocellular Carcinoma. 7: 219-232. PMID 33123501 DOI: 10.2147/JHC.S271790 |
0.585 |
|
| 2020 |
Gao Y, Kong F, Li G, Li C, Zheng S, Lin J, Wen X, Hu J, Wang X, Wu X, Xing H, Jia J, Jia Z, Guan Y, Li C, ... ... Niu J, et al. Coblopasvir and sofosbuvir for treatment of chronic hepatitis C virus infection in China: A single-arm, open-label, phase 3 trial. Liver International : Official Journal of the International Association For the Study of the Liver. PMID 33047868 DOI: 10.1111/Liv.14633 |
0.563 |
|
| 2020 |
Chen L, Shi X, Lv G, Sun X, Sun C, Cai Y, Niu J, Jin J, Liu N, Li W. The long-term outcomes of deceased-donor liver transplantation for primary biliary cirrhosis: a two-center study in China. Peerj. 8: e9563. PMID 32879788 DOI: 10.7717/Peerj.9563 |
0.421 |
|
| 2020 |
Ji F, Li J, Liu L, Liang J, Wang X, Liu J, Cai D, Huang R, Zhang J, Wang Q, Nan Y, Li J, Ye Q, Zhang M, Xu Q, ... ... Niu J, et al. High hepatitis C virus cure rates with approved interferon-free direct-acting antivirals among diverse mainland Chinese patients including genotypes 3a and 3b. Journal of Gastroenterology and Hepatology. PMID 32840326 DOI: 10.1111/Jgh.15192 |
0.542 |
|
| 2020 |
Wang X, Wang Z, Chi X, Wu R, Jin Q, Xu H, Gao X, Yu L, Chen Y, Shang J, Liu L, Zhang S, Jiang Y, Zhang M, Tong Q, ... ... Niu J, et al. Efficacy of a Combination of HBV RNA and HBeAg in Predicting HBeAg Seroconversion in Patients Treated with Entecavir for 144 Weeks. International Journal of Infectious Diseases : Ijid : Official Publication of the International Society For Infectious Diseases. PMID 32721532 DOI: 10.1016/J.Ijid.2020.07.031 |
0.5 |
|
| 2020 |
Fan R, Papatheodoridis G, Sun J, Innes H, Toyoda H, Xie Q, Mo S, Sypsa V, Guha IN, Kumada T, Niu J, Dalekos G, Yasuda S, Barnes E, Lian J, et al. aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis. Journal of Hepatology. PMID 32707225 DOI: 10.1016/J.Jhep.2020.07.025 |
0.496 |
|
| 2020 |
Gao Y, Li Y, Liu X, Zhang T, Yu G, Wang Y, Shi Y, Chi X, Wang X, Gao X, Wu R, Zhang Y, Hang L, Sun S, Guan Y, ... ... Niu J, et al. High prevalence of Clonorchis sinensis infections and coinfection with hepatitis virus in riverside villages in northeast China. Scientific Reports. 10: 11749. PMID 32678224 DOI: 10.1038/S41598-020-68684-X |
0.607 |
|
| 2020 |
Zhang H, Wang F, Zhu X, Chen Y, Chen H, Li X, Wu M, Li C, Liu J, Zhang Y, Ding Y, Niu J. Antiviral Activity and Pharmacokinetics of the HBV Capsid Assembly Modulator GLS4 in Patients with Chronic HBV Infection. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 32649736 DOI: 10.1093/Cid/Ciaa961 |
0.551 |
|
| 2020 |
Yang J, Wei P, Barbi J, Huang Q, Yang E, Bai Y, Nie J, Gao Y, Tao J, Lu Y, Xie C, Hou X, Ren J, Wu X, Meng J, ... ... Niu J, et al. The deubiquitinase USP44 promotes Treg function during inflammation by preventing FOXP3 degradation. Embo Reports. e50308. PMID 32644293 DOI: 10.15252/Embr.202050308 |
0.407 |
|
| 2020 |
Xu P, Xing X, Yu K, Lv Z, Cui H, Shi Y, Chang T, Zhang D, Zhang Y, Wang K, Lu J, Huang Q, Li X, Cui Y, Shi L, ... ... Niu J, et al. Profiles of COVID-19 clinical trials in the Chinese Clinical Trial Registry. Emerging Microbes & Infections. 1-19. PMID 32615862 DOI: 10.1080/22221751.2020.1791736 |
0.404 |
|
| 2020 |
Tong Y, Li Q, Li R, Xu Y, Pan Y, Niu J, Zhong J. A novel approach to display structural proteins of HCV quasispecies in patients reveals a key role of E2 HVR1 in viral evolution. Journal of Virology. PMID 32554700 DOI: 10.1128/Jvi.00622-20 |
0.518 |
|
| 2020 |
Chen J, Zhang Z, Wang N, Guo M, Chi X, Pan Y, Jiang J, Niu J, Ksimu S, Li JZ, Chen X, Wang Q. Author Correction: Role of HDAC9-FoxO1 Axis in the Transcriptional Program Associated with Hepatic Gluconeogenesis. Scientific Reports. 10: 8989. PMID 32461635 DOI: 10.1038/S41598-020-66085-8 |
0.448 |
|
| 2020 |
Gao X, Chi X, Wang X, Wu R, Xu H, Zhan M, Li D, Ding Y, Xu D, Niu J. IL-33 Inhibits Hepatitis B Virus through Its Receptor ST2 in Hydrodynamic HBV Mouse Model. Mediators of Inflammation. 2020: 1403163. PMID 32410845 DOI: 10.1155/2020/1403163 |
0.507 |
|
| 2020 |
Qi Y, Han L, Qi Y, Jin X, Zhang B, Niu J, Zhong J, Xu Y. Anti-flavivirus activity of polyoxometalate. Antiviral Research. 104813. PMID 32376449 DOI: 10.1016/J.Antiviral.2020.104813 |
0.46 |
|
| 2020 |
Yi C, Xia J, He L, Ling Z, Wang X, Yan Y, Wang J, Zhao X, Fan W, Sun X, Zhang R, Ye S, Zhang R, Xu Y, Ma L, ... ... Niu J, et al. Junctional and somatic hypermutation-induced CXC motif is critical for the recognition of a highly conserved epitope on HCV E2 by a human broadly neutralizing antibody. Cellular & Molecular Immunology. PMID 32235917 DOI: 10.1038/S41423-020-0403-1 |
0.497 |
|
| 2020 |
Fan R, Peng J, Xie Q, Tan D, Xu M, Niu J, Wang H, Ren H, Chen X, Wang M, Sheng J, Tang H, Bai X, Wu Y, Zhou B, et al. Combining HBV RNA and hepatitis B core-related antigen: guidance for safely stopping nucleos(t)ide analogues in HBeAg-positive chronic hepatitis B patients. The Journal of Infectious Diseases. PMID 32211776 DOI: 10.1093/Infdis/Jiaa136 |
0.556 |
|
| 2020 |
Chen J, Wang F, Zhou Y, Jiang J, Ksimu S, Zhang X, Li Z, Niu J, Wang Q. Chronic Hepatitis C Virus Infection Impairs Insulin Secretion by Regulation of p38δ MAPK-dependent Exocytosis in Pancreatic Beta cells. Clinical Science (London, England : 1979). PMID 32100852 DOI: 10.1042/Cs20190900 |
0.512 |
|
| 2020 |
Liu L, Zhang M, Hang L, Kong F, Yan H, Zhang Y, Feng X, Gao Y, Wang C, Ma H, Liu X, Zhan M, Pan Y, Xu H, Niu J. Evaluation of a new point-of-care oral anti-HCV test for screening of hepatitis C virus infection. Virology Journal. 17: 14. PMID 32005264 DOI: 10.1186/S12985-020-1293-7 |
0.526 |
|
| 2019 |
Miao XR, Niu JQ, Wang AQ, Wang DB, Fan J. Complete chloroplast genome sequence of , an important traditional Chinese medicine plant. Mitochondrial Dna. Part B, Resources. 4: 4163-4165. PMID 33366364 DOI: 10.1080/23802359.2019.1693301 |
0.37 |
|
| 2019 |
Shan S, You H, Niu J, Shang J, Xie W, Zhang Y, Li X, Ren H, Tang H, Ding H, Wang X, Nan Y, Dou X, Han T, Zhang L, et al. Baseline Characteristics and Treatment Patterns of the Patients Recruited to the China Registry of Hepatitis B. Journal of Clinical and Translational Hepatology. 7: 322-328. PMID 31915601 DOI: 10.14218/JCTH.2019.00052 |
0.585 |
|
| 2019 |
Zhan MR, Liu X, Zhang MY, Niu JQ. Isolated elevated aspartate aminotransferase in an asymptomatic woman due to macro-aspartate aminotransferase: A case report. World Journal of Clinical Cases. 7: 4414-4419. PMID 31911926 DOI: 10.12998/Wjcc.V7.I24.4414 |
0.391 |
|
| 2019 |
Ren T, Mackowiak B, Lin Y, Gao Y, Niu J, Gao B. Hepatic injury and inflammation alter ethanol metabolism and drinking behavior. Food and Chemical Toxicology : An International Journal Published For the British Industrial Biological Research Association. 111070. PMID 31870920 DOI: 10.1016/J.Fct.2019.111070 |
0.462 |
|
| 2019 |
Tan G, Yi Z, Song H, Xu F, Li F, Aliyari R, Zhang H, Du P, Ding Y, Niu J, Wang X, Su L, Qin FX, Cheng G. Type-I-IFN-Stimulated Gene TRIM5γ Inhibits HBV Replication by Promoting HBx Degradation. Cell Reports. 29: 3551-3563.e3. PMID 31825835 DOI: 10.1016/J.Celrep.2019.11.041 |
0.539 |
|
| 2019 |
Liu J, Li X, Zhang H, Chen G, Chen H, Hu Y, Niu J, Ding Y. Safety, pharmacokinetics and efficacy of donafenib in treating advanced hepatocellular carcinoma: report from a phase 1b trial. Die Pharmazie. 74: 688-693. PMID 31739839 DOI: 10.1691/ph.2019.9626 |
0.445 |
|
| 2019 |
Zhu Q, Wen XY, Zhang MY, Jin QL, Niu JQ. Mutation in PHKA2 leading to childhood glycogen storage disease type IXa: A case report and literature review. Medicine. 98: e17775. PMID 31725618 DOI: 10.1097/Md.0000000000017775 |
0.396 |
|
| 2019 |
Yang G, Feng J, Liu Y, Zhao M, Yuan Y, Yuan H, Yun H, Sun M, Bu Y, Liu L, Liu Z, Niu JQ, Yin M, Song X, Miao Z, et al. HAT1 signaling confers to assembly and epigenetic regulation of HBV cccDNA minichromosome. Theranostics. 9: 7345-7358. PMID 31695772 DOI: 10.7150/thno.37173 |
0.526 |
|
| 2019 |
Gao YH, Li QQ, Wang CG, Sun J, Wang XM, Li YJ, He XT, Xu HQ, Niu JQ. The role of IL22 polymorphisms on liver cirrhosis in patients with hepatitis B virus: A case control study. Medicine. 98: e17867. PMID 31689880 DOI: 10.1097/Md.0000000000017867 |
0.491 |
|
| 2019 |
Li X, Guo X, Ji H, Niu J, Gao P. Relationships between Metabolic Comorbidities and Occurrence, Severity, and Outcomes in Patients with Acute Pancreatitis: A Narrative Review. Biomed Research International. 2019: 2645926. PMID 31687382 DOI: 10.1155/2019/2645926 |
0.408 |
|
| 2019 |
Wu R, Geng D, Chi X, Wang X, Gao X, Xu H, Shi Y, Guan Y, Wang Y, Jin J, Ding Y, Niu J. Computational analysis of naturally occurring resistance-associated substitutions in genes , , and among 86 subtypes of hepatitis C virus worldwide. Infection and Drug Resistance. 12: 2987-3015. PMID 31571951 DOI: 10.2147/Idr.S218584 |
0.518 |
|
| 2019 |
Rao H, Xie Q, Shang J, Gao Z, Chen H, Sun Y, Jiang J, Niu J, Zhang L, Wang L, Zhao L, Li J, Yang R, Zhu S, Li R, et al. Real-world clinical outcomes among individuals with chronic HCV infection in China: CCgenos study. Antiviral Therapy. PMID 31566575 DOI: 10.3851/Imp3334 |
0.516 |
|
| 2019 |
Jin J, Xu H, Wu R, Gao N, Wu N, Li S, Niu J. Identification of key genes and pathways associated with different immune statuses of hepatitis B virus infection. Journal of Cellular and Molecular Medicine. PMID 31565863 DOI: 10.1111/Jcmm.14616 |
0.494 |
|
| 2019 |
Li X, Gao P, Niu J. Metabolic Comorbidities and Risk of Development and Severity of Drug-Induced Liver Injury. Biomed Research International. 2019: 8764093. PMID 31531370 DOI: 10.1155/2019/8764093 |
0.439 |
|
| 2019 |
Liu X, Xu H, Zhan M, Niu J. The Potential Effects of Diabetes Mellitus on Liver Fibrosis in Patients with Primary Biliary Cholangitis. Medical Science Monitor : International Medical Journal of Experimental and Clinical Research. 25: 6174-6180. PMID 31420961 DOI: 10.12659/Msm.916107 |
0.458 |
|
| 2019 |
Chen J, Zhou Y, Zhuang Y, Qin T, Guo M, Jiang J, Niu J, Li JZ, Chen X, Wang Q. The metabolic regulator small heterodimer partner contributes to the glucose and lipid homeostasis abnormalities induced by hepatitis C virus infection. Metabolism: Clinical and Experimental. 153954. PMID 31400386 DOI: 10.1016/J.Metabol.2019.153954 |
0.539 |
|
| 2019 |
Li Q, Zhang H, Qi Y, Wang J, Li J, Niu J. Antiviral effects of a niobium-substituted heteropolytungstate on hepatitis B virus-transgenic mice. Drug Development Research. PMID 31396981 DOI: 10.1002/Ddr.21586 |
0.466 |
|
| 2019 |
Ma Z, Wang X, Yin P, Wu R, Zhou L, Xu G, Niu J. Serum metabolome and targeted bile acid profiling reveals potential novel biomarkers for drug-induced liver injury. Medicine. 98: e16717. PMID 31374067 DOI: 10.1097/Md.0000000000016717 |
0.425 |
|
| 2019 |
Zhang MY, Niu JQ, Wen XY, Jin QL. Liver failure associated with benzbromarone: A case report and review of the literature. World Journal of Clinical Cases. 7: 1717-1725. PMID 31367632 DOI: 10.12998/Wjcc.V7.I13.1717 |
0.411 |
|
| 2019 |
Fan R, Zhou B, Xu M, Tan D, Niu J, Wang H, Ren H, Chen X, Wang M, Ning Q, Shi G, Sheng J, Tang H, Bai X, Liu S, et al. Association Between Negative Results From Tests for HBV DNA and RNA and Durability of Response After Discontinuation of Nucles(t)ide Analogue Therapy. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. PMID 31362119 DOI: 10.1016/J.Cgh.2019.07.046 |
0.528 |
|
| 2019 |
Liu J, Li X, Zhang H, Liu Y, Wu M, Niu J, Ding Y. S-amlodipine-bisoprolol combination therapy caused elevated transaminases and triglyceride levels in healthy Chinese subjects: a randomized controlled, open-label, multiple-dose pharmacokinetic interaction study. Expert Opinion On Drug Metabolism & Toxicology. PMID 31359804 DOI: 10.1080/17425255.2019.1650913 |
0.408 |
|
| 2019 |
Chi X, Wang M, Pan Y, Jiang J, Jiang T, Yan H, Wu R, Wang X, Gao X, Niu J. Inosine triphosphate pyrophosphatase polymorphisms are predictors of anemia in Chinese patients with chronic hepatitis C during therapy with ribavirin and interferon. Journal of Gastroenterology and Hepatology. PMID 31359493 DOI: 10.1111/Jgh.14812 |
0.508 |
|
| 2019 |
Wang Y, Rao H, Chi X, Li B, Liu H, Wu L, Zhang H, Liu S, Zhou G, Li N, Niu J, Wei L, Zhao J. Detection of residual HCV-RNA in patients who have achieved sustained virological response is associated with persistent histological abnormality. Ebiomedicine. PMID 31345785 DOI: 10.1016/J.Ebiom.2019.07.043 |
0.535 |
|
| 2019 |
He X, Xu H, Wang X, Wu J, Niu J, Gao P. Associations between the single nucleotide polymorphisms of APOBEC3A, APOBEC3B and APOBEC3H, and chronic hepatitis B progression and hepatocellular carcinoma in a Chinese population. Molecular Medicine Reports. PMID 31322199 DOI: 10.3892/Mmr.2019.10455 |
0.461 |
|
| 2019 |
Hou JL, Zhao W, Lee C, Hann HW, Peng CY, Tanwandee T, Morozov V, Klinker H, Sollano JD, Streinu-Cercel A, Cheinquer H, Xie Q, Wang YM, Wei L, Jia JD, ... ... Niu J, et al. Outcomes of Long-term Treatment of Chronic HBV Infection With Entecavir or Other Agents From a Randomized Trial in 24 Countries. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. PMID 31306800 DOI: 10.1016/J.Cgh.2019.07.010 |
0.521 |
|
| 2019 |
Seo W, Gao Y, He Y, Sun J, Xu H, Feng D, Hee Park S, Cho YE, Guillot A, Ren T, Wu R, Wang J, Kim SJ, Hwang S, Liangpunsakul S, ... ... Niu J, et al. ALDH2 deficiency promotes alcohol-associated liver cancer by activating oncogenic pathways via oxidized DNA enriched extracellular vesicles. Journal of Hepatology. PMID 31279903 DOI: 10.1016/J.Jhep.2019.06.018 |
0.42 |
|
| 2019 |
Li Y, Wang X, Yu G, Sun H, Lv J, Chi X, Wu R, Gao X, Niu J. The association of hepatitis c virus infection status with serum glucose levels. Bmc Gastroenterology. 19: 86. PMID 31195990 DOI: 10.1186/S12876-019-1003-3 |
0.509 |
|
| 2019 |
Meng J, Xu H, Sui D, Jiang J, Li J, Gao Y, Niu J. A retrospective serological survey of hepatitis B virus infection in Northeast China. Bmc Infectious Diseases. 19: 440. PMID 31109300 DOI: 10.1186/S12879-019-4091-3 |
0.544 |
|
| 2019 |
Jiang C, Zhou Q, Jin M, Niu J, Gao Y. Congenital hepatic fibrosis with polycystic kidney disease: Two case reports. Medicine. 98: e15600. PMID 31096464 DOI: 10.1097/Md.0000000000015600 |
0.452 |
|
| 2019 |
Yan Y, Wang X, Lou P, Hu Z, Qu P, Li D, Li Q, Xu Y, Niu J, He Y, Zhong J, Huang Z. A nanoparticle-based HCV vaccine with enhanced potency. The Journal of Infectious Diseases. PMID 31074790 DOI: 10.1093/Infdis/Jiz228 |
0.473 |
|
| 2019 |
Li X, Wang L, Li D, Niu J, Gao P. Dyslipidemia is a Risk Factor for the Incidence and Severity of Drug-Induced Liver Injury (DILI): A Retrospective Population-Based Study in China. Medical Science Monitor : International Medical Journal of Experimental and Clinical Research. 25: 3344-3353. PMID 31059494 DOI: 10.12659/Msm.916687 |
0.441 |
|
| 2019 |
Liu X, Meng J, Xu H, Niu J. Alpha-fetoprotein to transaminase ratio is related to higher diagnostic efficacy for hepatocellular carcinoma. Medicine. 98: e15414. PMID 31027143 DOI: 10.1097/Md.0000000000015414 |
0.518 |
|
| 2019 |
Cui W, Zhang W, Yuan X, Liu S, Li M, Niu J, Zhang P, Li D. Vitamin A deficiency execrates Lewis lung carcinoma via induction of type 2 innate lymphoid cells and alternatively activates macrophages. Food Science & Nutrition. 7: 1288-1294. PMID 31024701 DOI: 10.1002/fsn3.961 |
0.388 |
|
| 2019 |
Liu L, Xu H, Hu Y, Shang J, Jiang J, Yu L, Zhao C, Zhang D, Zhang X, Li J, Li W, Wu Y, Hu D, Wang X, Zhao Q, ... ... Niu J, et al. Hepatitis C screening in hospitals: find the missing patients. Virology Journal. 16: 47. PMID 30992019 DOI: 10.1186/S12985-019-1157-1 |
0.536 |
|
| 2019 |
Liang X, Gao Z, Xie Q, Zhang J, Sheng J, Cheng J, Chen C, Mao Q, Zhao W, Ren H, Tan D, Niu J, Chen S, Pan C, Tang H, et al. Long-term efficacy and safety of tenofovir disoproxil fumarate in Chinese patients with chronic hepatitis B: 5-year results. Hepatology International. PMID 30977033 DOI: 10.1007/S12072-019-09943-6 |
0.547 |
|
| 2019 |
Wang WJ, Xiao P, Xu HQ, Niu JQ, Gao YH. Growing burden of alcoholic liver disease in China: A review. World Journal of Gastroenterology. 25: 1445-1456. PMID 30948908 DOI: 10.3748/Wjg.V25.I12.1445 |
0.421 |
|
| 2019 |
Zhang C, Wang XM, Li SR, Twelkmeyer T, Wang WH, Zhang SY, Wang SF, Chen JZ, Jin X, Wu YZ, Chen XW, Wang SD, Niu JQ, Chen HR, Tang H. NKG2A is a NK cell exhaustion checkpoint for HCV persistence. Nature Communications. 10: 1507. PMID 30944315 DOI: 10.1038/S41467-019-09212-Y |
0.524 |
|
| 2019 |
Shen Z, Zhu X, Zhang H, Chen H, Niu J, Chen G, Li X, Ding Y. Pharmacokinetic Profile of a Generic Formulation of Sofosbuvir and Its Metabolite GS-331007 in Healthy Chinese Subjects. Clinical Pharmacology in Drug Development. PMID 30900816 DOI: 10.1002/Cpdd.674 |
0.454 |
|
| 2019 |
Deng L, Jiang W, Wang X, Merz A, Hiet MS, Chen Y, Pan X, Jiu Y, Yang Y, Yu B, He Y, Tu Z, Niu J, Bartenschlager R, Long G. Syntenin regulates Hepatitis C virus sensitivity to neutralizing antibody by promoting E2 secretion through exosomes. Journal of Hepatology. PMID 30880226 DOI: 10.1016/J.Jhep.2019.03.006 |
0.542 |
|
| 2019 |
Song H, Tan G, Yang Y, Cui A, Li H, Li T, Wu Z, Yang M, Lv G, Chi X, Niu J, Zhu K, Crispe IN, Su L, Tu Z. Hepatitis B Virus-Induced Imbalance of Inflammatory and Antiviral Signaling by Differential Phosphorylation of STAT1 in Human Monocytes. Journal of Immunology (Baltimore, Md. : 1950). PMID 30842274 DOI: 10.4049/Jimmunol.1800848 |
0.51 |
|
| 2019 |
Xu H, Sun L, He Y, Yuan X, Niu J, Su J, Li D. Deficiency in IL-33/ST2 Axis Reshapes Mitochondrial Metabolism in Lipopolysaccharide-Stimulated Macrophages. Frontiers in Immunology. 10: 127. PMID 30774633 DOI: 10.3389/fimmu.2019.00127 |
0.376 |
|
| 2019 |
Zhang H, Xu H, Wu R, Yu G, Sun H, Lv J, Wang X, Chi X, Gao X, Kong F, Zhang M, Hang L, Jiang J, Pan Y, Niu J. Association of Hepatitis C and B Virus Infection with CKD and Impact of Hepatitis C Treatment on CKD. Scientific Reports. 9: 1910. PMID 30760762 DOI: 10.1038/S41598-018-36437-6 |
0.563 |
|
| 2019 |
Shen T, Liu Y, Shang J, Xie Q, Li J, Yan M, Xu J, Niu J, Liu J, Watkins PB, Aithal GP, Andrade RJ, Dou X, Yao L, Lv F, et al. Incidence and Etiology of Drug-Induced Liver Injury in Mainland China. Gastroenterology. PMID 30742832 DOI: 10.1053/J.Gastro.2019.02.002 |
0.426 |
|
| 2019 |
Yao Y, Yang B, Chen Y, Wang H, Hu X, Zhou Y, Gao X, Lu M, Niu J, Wen Z, Wu C, Chen X. RNA-Binding Motif Protein 24 (RBM24) Is Involved in pgRNA Packaging by Mediating Interaction between HBV Polymerase and the Epsilon Element. Journal of Virology. PMID 30626666 DOI: 10.1128/Jvi.02161-18 |
0.521 |
|
| 2018 |
Meng J, Xu H, Liu X, Wu R, Niu J. Increased red cell width distribution to lymphocyte ratio is a predictor of histologic severity in primary biliary cholangitis. Medicine. 97: e13431. PMID 30508955 DOI: 10.1097/Md.0000000000013431 |
0.446 |
|
| 2018 |
Wen S, Wu Y, Pan Y, Cao M, Zhao D, Wang C, Wang C, Kong F, Li J, Niu J, Jiang J. Association of IL-10 and IL-10RA single nucleotide polymorphisms with the responsiveness to HBV vaccination in Chinese infants of HBsAg(+)/HBeAg(-) mothers: a nested case-control study. Bmj Open. 8: e022334. PMID 30498038 DOI: 10.1136/Bmjopen-2018-022334 |
0.474 |
|
| 2018 |
Gao YH, Wang JY, Liu PY, Sun J, Wang XM, Wu RH, He XT, Tu ZK, Wang CG, Xu HQ, Niu JQ. Iron metabolism disorders in patients with hepatitis B-related liver diseases. World Journal of Clinical Cases. 6: 600-610. PMID 30430115 DOI: 10.12998/Wjcc.V6.I13.600 |
0.533 |
|
| 2018 |
Zhang T, Hu J, Wang X, Zhao X, Li Z, Niu J, Steer CJ, Zheng G, Song G. MicroRNA-378 Promotes Hepatic Inflammation and Fibrosis via Modulation of the NFκB-TNFα Pathway. Journal of Hepatology. PMID 30218679 DOI: 10.1016/j.jhep.2018.08.026 |
0.456 |
|
| 2018 |
Li X, Chen H, Niu J, Chen G, Shen G, Massetto B, Brainard DM, Zhu X, Zhang H, Ding Y. Pharmacokinetics, Safety, and Tolerability of the Direct-Acting Hepatitis C Antiviral Sofosbuvir in Healthy Chinese Subjects. Clinical Therapeutics. PMID 30185395 DOI: 10.1016/J.Clinthera.2018.07.018 |
0.438 |
|
| 2018 |
Wang S, Tao Y, Tao Y, Jiang J, Yan L, Wang C, Ding Y, Yu J, Zhao D, Chi X, Wang X, Wu R, Gao X, Shi Y, Guan Y, ... ... Niu J, et al. Epidemiological study of hepatitis B and hepatitis C infections in Northeastern China and the beneficial effect of the vaccination strategy for hepatitis B: a cross-sectional study. Bmc Public Health. 18: 1088. PMID 30176842 DOI: 10.1186/S12889-018-5984-6 |
0.588 |
|
| 2018 |
Zhang Y, Xu H, Chi X, Fan Y, Shi Y, Niu J. High level of serum Cripto-1 in hepatocellular carcinoma, especially with hepatitis B virus infection. Medicine. 97: e11781. PMID 30170372 DOI: 10.1097/Md.0000000000011781 |
0.502 |
|
| 2018 |
Gao Y, Zhou Z, Ren T, Kim SJ, He Y, Seo W, Guillot A, Ding Y, Wu R, Shao S, Wang X, Zhang H, Wang W, Feng D, Xu M, ... ... Niu J, et al. Alcohol inhibits T-cell glucose metabolism and hepatitis in ALDH2-deficient mice and humans: roles of acetaldehyde and glucocorticoids. Gut. PMID 30121625 DOI: 10.1136/Gutjnl-2018-316221 |
0.467 |
|
| 2018 |
Jin J, Xu H, Wu R, Niu J, Li S. Aberrant DNA methylation profile of hepatitis B virus infection. Journal of Medical Virology. PMID 30118556 DOI: 10.1002/Jmv.25284 |
0.532 |
|
| 2018 |
Wang ZF, Wang MY, Yu DH, Zhao Y, Xu HM, Zhong S, Sun WY, He YF, Niu JQ, Gao PJ, Li HJ. Therapeutic effect of chitosan on CCl4‑induced hepatic fibrosis in rats. Molecular Medicine Reports. PMID 30085342 DOI: 10.3892/mmr.2018.9343 |
0.487 |
|
| 2018 |
Li X, Zhang H, Zhu X, Li C, Chen H, Liu J, Chen G, Wu M, Liu C, Shen Z, Niu J, Liu B, Ding Y. The pharmacokinetics and safety profile of desmopressin in two oral tablet formulations in healthy Chinese subjects under fasting and fed conditions
. International Journal of Clinical Pharmacology and Therapeutics. PMID 30049304 DOI: 10.5414/CP203241 |
0.377 |
|
| 2018 |
Zhang Y, Zhao Y, Wu J, Liangpunsakul S, Niu J, Wang L. MicroRNA-26-5p functions as a new inhibitor of hepatoblastoma by repressing lin-28 homolog B and aurora kinase a expression. Hepatology Communications. 2: 861-871. PMID 30027143 DOI: 10.1002/hep4.1185 |
0.405 |
|
| 2018 |
Li X, Liu C, Zhu X, Wei H, Zhang H, Chen H, Chen G, Yang D, Sun H, Shen Z, Zhang Y, Li W, Yang J, Liu Y, Lai X, ... ... Niu J, et al. Evaluation of Tolerability, Pharmacokinetics and Pharmacodynamics of Vicagrel, a Novel P2Y12 Antagonist, in Healthy Chinese Volunteers. Frontiers in Pharmacology. 9: 643. PMID 29973877 DOI: 10.3389/Fphar.2018.00643 |
0.388 |
|
| 2018 |
Cao M, Wu Y, Wen S, Pan Y, Wang C, Zhang X, Kong F, Lu Y, Wang C, Niu J, Li J, Jiang J. 20 μg hepatitis B vaccination reduced the risk of low responsiveness in infants with HLA-II risk genotype of HBsAg positive mothers. Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases. PMID 29883771 DOI: 10.1016/J.Meegid.2018.06.006 |
0.45 |
|
| 2018 |
Zhang Y, Mi X, Song Z, Li Y, YingShi, Niu J. Cripto-1 promotes resistance to drug-induced apoptosis by activating the TAK-1/NF-κB/survivin signaling pathway. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 104: 729-737. PMID 29807222 DOI: 10.1016/j.biopha.2018.05.063 |
0.388 |
|
| 2018 |
Wu J, He S, Xu H, Chi X, Sun J, Wang X, Gao X, Wu R, Shao M, Zhao H, Jia J, Wang C, Niu J. Non-alcoholic fatty liver disease incidence, remission and risk factors among a general Chinese population with a 6-year follow-up. Scientific Reports. 8: 7557. PMID 29765064 DOI: 10.1038/S41598-018-25641-Z |
0.452 |
|
| 2018 |
Shan S, Wei W, Kong Y, Niu J, Shang J, Xie W, Zhang Y, Ren H, Tang H, Ding H, Nan Y, Dou X, Han T, Xu X, Duan Z, et al. China Registry of Hepatitis B (CR-HepB): Protocol and implementation of a nationwide hospital-based registry of hepatitis B. Scandinavian Journal of Public Health. 1403494818772188. PMID 29716439 DOI: 10.1177/1403494818772188 |
0.545 |
|
| 2018 |
Zhang Y, Tao LN, Qu XY, Niu JQ, Ding YH, Zhang SX. Efficacy and safety of ceftazidime-avibactam in the treatment of complicated intra-abdominal infections (CIAIs) and complicated urinary tract infections (CUTIs): A meta-analysis of randomized controlled trials. Revista Da Associacao Medica Brasileira (1992). 64: 253-263. PMID 29641778 DOI: 10.1590/1806-9282.64.03.253 |
0.423 |
|
| 2018 |
Zhang H, Zhu X, Li Q, Lou J, Sun J, Shen Z, Chen H, Li X, Wu M, Li C, Liu J, Liu C, Hu Y, Wang J, Chen G, ... ... Niu J, et al. Clinical evaluation of efficacy, tolerability and pharmacokinetics of yimitasvir phosphate in patients infected with hepatitis C virus. The Journal of Pharmacy and Pharmacology. PMID 29630721 DOI: 10.1111/Jphp.12916 |
0.551 |
|
| 2018 |
Wei L, Wang FS, Zhang MX, Jia JD, Yakovlev AA, Xie W, Burnevich E, Niu JQ, Jung YJ, Jiang XJ, Xu M, Chen XY, Xie Q, Li J, Hou JL, et al. Daclatasvir plus asunaprevir in treatment-naïve patients with hepatitis C virus genotype 1b infection. World Journal of Gastroenterology. 24: 1361-1372. PMID 29599611 DOI: 10.3748/wjg.v24.i12.1361 |
0.577 |
|
| 2018 |
Zhang Y, Shi Y, Wu R, Wang X, Gao X, Niu J. Primary biliary cholangitis is more severe in previous hepatitis B virus infection patients. European Journal of Gastroenterology & Hepatology. PMID 29462025 DOI: 10.1097/Meg.0000000000001100 |
0.564 |
|
| 2018 |
Li Q, Tong Y, Xu Y, Niu J, Zhong J. Genetic Analysis of Serum-derived HCV Defective Genomes Revealed Novel Viral Cis-Elements for Virus Replication and Assembly. Journal of Virology. PMID 29367245 DOI: 10.1128/Jvi.02182-17 |
0.506 |
|
| 2017 |
Liu MX, Wen XY, Leung YK, Zheng YJ, Jin MS, Jin QL, Niu JQ. Hemolytic anemia in alcoholic liver disease: Zieve syndrome: A case report and literature review. Medicine. 96: e8742. PMID 29381966 DOI: 10.1097/Md.0000000000008742 |
0.39 |
|
| 2017 |
Zhong S, Fan Y, Yan Q, Fan X, Wu B, Han Y, Zhang Y, Chen Y, Zhang H, Niu J. The therapeutic effect of silymarin in the treatment of nonalcoholic fatty disease: A meta-analysis (PRISMA) of randomized control trials. Medicine. 96: e9061. PMID 29245314 DOI: 10.1097/MD.0000000000009061 |
0.449 |
|
| 2017 |
Yang Z, Wang X, Chi X, Zhao F, Guo J, Ma P, Zhong J, Niu J, Pan X, Long G. Correction for Yang et al., "Neglected but Important Role of Apolipoprotein E Exchange in Hepatitis C Virus Infection". Journal of Virology. 91. PMID 29191986 DOI: 10.1128/Jvi.01642-17 |
0.479 |
|
| 2017 |
Hua R, Jiang X, Qi L, Guan S, Kuai Z, Qiao Y, Xu Y, Gong X, Shi Y, Kong W, Niu J, Zhang H, Shan Y. Screening HCV genotype-specific epitope peptides based on conserved sequence analysis and B cell epitope prediction in HCV E2 region. Immunologic Research. PMID 29151181 DOI: 10.1007/s12026-017-8962-7 |
0.52 |
|
| 2017 |
Luo P, Yin P, Hua R, Tan Y, Li Z, Qiu G, Yin Z, Xie X, Wang X, Chen W, Zhou L, Wang X, Li Y, Chen H, Gao L, ... ... Niu J, et al. A large-scale, multi-center serum metabolite biomarkers identification study for the early detection of hepatocellular carcinoma. Hepatology (Baltimore, Md.). PMID 28960374 DOI: 10.1002/Hep.29561 |
0.46 |
|
| 2017 |
Li H, Zhai N, Wang Z, Song H, Yang Y, Cui A, Li T, Wang G, Niu J, Crispe IN, Su L, Tu Z. Regulatory NK cells mediated between immunosuppressive monocytes and dysfunctional T cells in chronic HBV infection. Gut. PMID 28899983 DOI: 10.1136/Gutjnl-2017-314098 |
0.5 |
|
| 2017 |
Du Y, Chi X, Wang C, Jiang J, Kong F, Yan H, Wang X, Li J, Wu NC, Dai L, Zhang TH, Shu S, Zhou J, Yoshizawa JM, Li X, ... ... Niu J, et al. Quantifying perinatal transmission of Hepatitis B viral quasispecies by tag linkage deep sequencing. Scientific Reports. 7: 10168. PMID 28860476 DOI: 10.1038/S41598-017-10591-9 |
0.508 |
|
| 2017 |
Yu R, Tan D, Ning Q, Niu J, Bai X, Chen S, Cheng J, Yu Y, Wang H, Xu M, Shi G, Wan M, Chen X, Tang H, Sheng J, et al. Association of baseline vitamin D level with genetic determinants and virologic response in patients with chronic hepatitis B. Hepatology Research : the Official Journal of the Japan Society of Hepatology. PMID 28834607 DOI: 10.1111/Hepr.12972 |
0.481 |
|
| 2017 |
Ren T, Wang H, Wu R, Niu J. Gamma-Glutamyl Transpeptidase-to-Platelet Ratio Predicts Significant Liver Fibrosis of Chronic Hepatitis B Patients in China. Gastroenterology Research and Practice. 2017: 7089702. PMID 28831282 DOI: 10.1155/2017/7089702 |
0.542 |
|
| 2017 |
Chen J, Zhang Z, Wang N, Guo M, Chi X, Pan Y, Jiang J, Niu J, Ksimu S, Li JZ, Chen X, Wang Q. Role of HDAC9-FoxO1 Axis in the Transcriptional Program Associated with Hepatic Gluconeogenesis. Scientific Reports. 7: 6102. PMID 28733598 DOI: 10.1038/S41598-017-06328-3 |
0.5 |
|
| 2017 |
Wang Z, Gao Y, Zhang C, Hu H, Guo D, Xu Y, Xu Q, Zhang W, Deng S, Lv P, Yang Y, Ding Y, Li Q, Weng C, Chen X, ... ... Niu J, et al. Quinolinate Phosphoribosyltransferase is an Antiviral Host Factor Against Hepatitis C Virus Infection. Scientific Reports. 7: 5876. PMID 28724915 DOI: 10.1038/S41598-017-06254-4 |
0.534 |
|
| 2017 |
Wu H, Tao J, Li X, Zhang T, Zhao L, Wang Y, Zhang L, Xiong J, Zeng Z, Zhan N, Steer CJ, Che L, Dong M, Wang X, Niu J, et al. MicroRNA-206 Prevents the Pathogenesis of Hepatocellular Carcinoma Via Modulating Expression of cMet and Cdk6. Hepatology (Baltimore, Md.). PMID 28714063 DOI: 10.1002/hep.29374 |
0.436 |
|
| 2017 |
Zhang SQ, Yang Z, Cai XL, Zhao M, Sun MM, Li J, Feng GX, Feng JY, Ye LH, Niu JQ, Zhang XD. miR-511 promotes the proliferation of human hepatoma cells by targeting the 3'UTR of B cell translocation gene 1 (BTG1) mRNA. Acta Pharmacologica Sinica. PMID 28603285 DOI: 10.1038/aps.2017.62 |
0.391 |
|
| 2017 |
Li X, Jin Q, Xu H, Zhang Z, Zhou H, Yan D, Li D, Gao P, Niu J. Chronic hepatitis B patients with high liver fibrosis levels should receive antiviral treatment. Experimental and Therapeutic Medicine. 13: 3624-3630. PMID 28588691 DOI: 10.3892/Etm.2017.4422 |
0.521 |
|
| 2017 |
Ding Y, Zhang H, Li X, Li C, Chen G, Chen H, Wu M, Niu J. Safety, pharmacokinetics and pharmacogenetics of a single ascending dose of pradefovir, a novel liver-targeting, anti-hepatitis B virus drug, in healthy Chinese subjects. Hepatology International. PMID 28560658 DOI: 10.1007/s12072-017-9797-y |
0.517 |
|
| 2017 |
Qu XY, Tao LN, Zhang SX, Sun JM, Niu JQ, Ding YH, Song YQ. Corrigendum to "The role of Ntcp, Oatp2, Bsep and Mrp2 in liver injury induced by Dioscorea bulbifera L. and Diosbulbin B in mice" [Environ. Toxicol. Pharmacol. 51 (2017) 16-22]. Environmental Toxicology and Pharmacology. PMID 28506607 DOI: 10.1016/j.etap.2017.05.001 |
0.431 |
|
| 2017 |
Xu H, Kong W, Liu L, Chi X, Wang X, Wu R, Gao X, Wang H, Qu L, Qi Y, Pan Y, Niu J. Accuracy of M2BPGi, compared with Fibro Scan®, in analysis of liver fibrosis in patients with hepatitis C. Bmc Gastroenterology. 17: 62. PMID 28486931 DOI: 10.1186/S12876-017-0618-5 |
0.536 |
|
| 2017 |
Li X, Jin Q, Zhang H, Jing X, Ding Z, Zhou H, Zhang Z, Yan D, Li D, Gao P, Niu J. Changes in liver stiffness and its associated factors during oral antiviral therapy in Chinese patients with chronic hepatitis B. Experimental and Therapeutic Medicine. 13: 1169-1175. PMID 28450959 DOI: 10.3892/Etm.2017.4065 |
0.526 |
|
| 2017 |
Li C, Xu J, Zheng Y, Chen G, Wang J, Ma L, Qiao Y, Niu J, Wu M, Zhang H, Li X, Chen H, Zhu X, Liu C, Ding Y. Bioequivalence and Pharmacokinetic Profiles of Agomelatine 25-mg Tablets in Healthy Chinese Subjects: A Four-Way Replicate Crossover Study Demonstrating High Intra- and Inter-individual Variations. Chemical & Pharmaceutical Bulletin. PMID 28392509 DOI: 10.1248/cpb.c16-00866 |
0.392 |
|
| 2017 |
Qu XY, Tao LN, Zhang SX, Sun JM, Niu JQ, Ding YH, Song YQ. The role of Ntcp, Oatp2, Bsep and Mrp2 in liver injury induced by Dioscorea bulbifera L. and Diosbulbin B in mice. Environmental Toxicology and Pharmacology. 51: 16-22. PMID 28262508 DOI: 10.1016/j.etap.2017.02.023 |
0.462 |
|
| 2017 |
Tan G, Xiao Q, Song H, Ma F, Xu F, Peng D, Li N, Wang X, Niu J, Gao P, Qin FX, Cheng G. Type I IFN augments IL-27-dependent TRIM25 expression to inhibit HBV replication. Cellular & Molecular Immunology. PMID 28194021 DOI: 10.1038/Cmi.2016.67 |
0.56 |
|
| 2017 |
Zhang C, Hua R, Cui Y, Wang S, Yan H, Li D, Zhang Y, Tu Z, Hao P, Chen X, Zhong J, Niu J, Jin X. Comprehensive mapping of antigen specific T cell responses in hepatitis C virus infected patients with or without spontaneous viral clearance. Plos One. 12: e0171217. PMID 28170421 DOI: 10.1371/Journal.Pone.0171217 |
0.529 |
|
| 2017 |
Wu J, Xu H, He X, Yuan Y, Wang C, Sun J, He S, Niu J. Six-year changes in the prevalence of obesity and obesity-related diseases in Northeastern China from 2007 to 2013. Scientific Reports. 7: 41518. PMID 28128316 DOI: 10.1038/Srep41518 |
0.379 |
|
| 2017 |
He XT, Xu HQ, Wang XM, He XS, Niu JQ, Gao PJ. Association between polymorphisms of the APOBEC3G gene and chronic hepatitis B viral infection and hepatitis B virus-related hepatocellular carcinoma. World Journal of Gastroenterology. 23: 232-241. PMID 28127197 DOI: 10.3748/Wjg.V23.I2.232 |
0.552 |
|
| 2017 |
Ding YH, Liu B, Zhang X, Sun L, Zhang H, Luo H, Sun YF, Liu CJ, Zhang Q, Cao YC, Chen H, Niu JQ. Tolerability and efficacy of pegylated consensus interferon-α in the treatment of chronic hepatitis C. Experimental and Therapeutic Medicine. 13: 9-16. PMID 28123460 DOI: 10.3892/etm.2016.3914 |
0.512 |
|
| 2017 |
Zhai N, Li H, Song H, Yang Y, Cui A, Li T, Niu J, Crispe IN, Su L, Tu Z. Hepatitis C Virus Induces MDSCs-Like Monocytes through TLR2/PI3K/AKT/STAT3 Signaling. Plos One. 12: e0170516. PMID 28114346 DOI: 10.1371/Journal.Pone.0170516 |
0.531 |
|
| 2016 |
You H, Kong Y, Hou J, Wei L, Zhang Y, Niu J, Han T, Ou X, Dou X, Shang J, Tang H, Xie Q, Ding H, Ren H, Xu X, et al. Female gender lost protective effect against disease progression in elderly patients with chronic hepatitis B. Scientific Reports. 6: 37498. PMID 27892487 DOI: 10.1038/Srep37498 |
0.465 |
|
| 2016 |
Ding Y, Lou J, Cheng H, Li X, Wu M, Li C, Liu J, Liu C, Li Q, Zhang H, Niu J. Tolerability, pharmacokinetics and antiviral activity of rHSA/IFNα2a for the treatment of chronic hepatitis B infection. British Journal of Clinical Pharmacology. PMID 27862178 DOI: 10.1111/bcp.13184 |
0.523 |
|
| 2016 |
Wang J, Du M, Huang H, Chen R, Niu J, Jiang J, Zhuang H, Lu F. Consistent loss of serum HBV RNA might predict the "para-functional cure" of chronic hepatitis B. Journal of Hepatology. PMID 27826054 DOI: 10.1016/J.Jhep.2016.10.034 |
0.521 |
|
| 2016 |
Zhang Q, Wang Y, Zhai N, Song H, Li H, Yang Y, Li T, Guo X, Chi B, Niu J, Crispe IN, Su L, Tu Z. HCV core protein inhibits polarization and activity of both M1 and M2 macrophages through the TLR2 signaling pathway. Scientific Reports. 6: 36160. PMID 27786268 DOI: 10.1038/Srep36160 |
0.508 |
|
| 2016 |
Wang C, Wang C, Jia ZF, Wu X, Wen SM, Kong F, Hu KQ, Li J, Jiang J, Niu JQ. Protective effect of an improved immunization practice of mother-to-infant transmission of hepatitis B virus and risk factors associated with immunoprophylaxis failure. Medicine. 95: e4390. PMID 27559947 DOI: 10.1097/Md.0000000000004390 |
0.459 |
|
| 2016 |
Yang Z, Wang X, Chi X, Zhao F, Guo J, Ma P, Zhong J, Niu J, Pan X, Long G. Neglected but Important Role of Apolipoprotein E Exchange in Hepatitis C Virus Infection. Journal of Virology. PMID 27535051 DOI: 10.1128/Jvi.01353-16 |
0.532 |
|
| 2016 |
Liu GD, Zhou RD, Zha YT, Cai J, Niu JQ, Gao PJ, Liu LL. [Study on Indicator Densitometry Determination Method of Hemodynamic Parameters]. Guang Pu Xue Yu Guang Pu Fen Xi = Guang Pu. 36: 662-6. PMID 27400501 |
0.37 |
|
| 2016 |
Hua R, Hua F, Jiao Y, Pan Y, Yang X, Peng S, Niu J. Mutational analysis of ATP7B in Chinese Wilson disease patients. American Journal of Translational Research. 8: 2851-61. PMID 27398169 |
0.394 |
|
| 2016 |
Pang X, Wang Z, Zhai N, Zhang Q, Song H, Zhang Y, Li T, Li H, Su L, Niu J, Tu Z. IL-10 plays a central regulatory role in the cytokines induced by hepatitis C virus core protein and polyinosinic acid:polycytodylic acid. International Immunopharmacology. 38: 284-290. PMID 27337528 DOI: 10.1016/J.Intimp.2016.06.013 |
0.509 |
|
| 2016 |
Phan TT, Sun B, Niu JQ, Tan QL, Li J, Yang LT, Li YR. Overexpression of sugarcane gene SoSnRK2.1 confers drought tolerance in transgenic tobacco. Plant Cell Reports. PMID 27316630 DOI: 10.1007/s00299-016-2004-0 |
0.374 |
|
| 2016 |
Fan W, Xie S, Zhao X, Li N, Chang C, Li L, Yu G, Chi X, Pan Y, Niu J, Zhong J, Sun B. IFN-λ4 desensitizes the response to IFN-α treatment in chronic hepatitis C through long-term induction of USP18. The Journal of General Virology. PMID 27302182 DOI: 10.1099/Jgv.0.000522 |
0.504 |
|
| 2016 |
Rao HY, Li H, Chen H, Shang J, Xie Q, Gao ZL, Li J, Sun Y, Jiang J, Wang L, Zhao L, Zhang L, Yang W, Niu J, Gong Z, et al. Real world treatment patterns and clinical outcomes of hcv treatment-naive patients in china: an interim analysis from the ccgenos study. Journal of Gastroenterology and Hepatology. PMID 27289083 DOI: 10.1111/Jgh.13467 |
0.533 |
|
| 2016 |
Gao L, Chen X, Zhang L, Wu D, Zhao H, Niu J. Association of IL-10 polymorphisms with hepatitis B virus infection and outcome in Han population. European Journal of Medical Research. 21: 23. PMID 27245049 DOI: 10.1186/s40001-016-0218-9 |
0.518 |
|
| 2016 |
Sun J, Ma H, Xie Q, Xie Y, Sun Y, Wang H, Shi G, Wan M, Niu J, Ning Q, Yu Y, Zhou H, Cheng J, Kang W, Xie Y, et al. Response-guided peginterferon therapy in patients with HBeAg-positive chronic hepatitis B: A randomized controlled study. Journal of Hepatology. PMID 27238752 DOI: 10.1016/J.Jhep.2016.05.024 |
0.547 |
|
| 2016 |
Zang X, Jiang Y, Li X, DU Y, Niu J. Characteristics of CD4(+)CD25(+)Foxp3(+) regulatory T cells in patients with multiple organ dysfunction syndrome. Experimental and Therapeutic Medicine. 11: 1908-1912. PMID 27168826 DOI: 10.3892/etm.2016.3157 |
0.391 |
|
| 2016 |
Wang H, Xu H, Qu L, Wang X, Wu R, Gao X, Jin Q, Niu J. Red blood cell distribution width and globulin, noninvasive indicators of fibrosis and inflammation in chronic hepatitis patients. European Journal of Gastroenterology & Hepatology. PMID 27167453 DOI: 10.1097/Meg.0000000000000662 |
0.528 |
|
| 2016 |
Wang X, Bots ML, Yang F, Sun J, He S, Hoes AW, Niu J, Vaartjes I. A comparison of the prevalence and clustering of major cardiovascular risk factors in the Netherlands and China. European Journal of Preventive Cardiology. PMID 27154590 DOI: 10.1177/2047487316648474 |
0.363 |
|
| 2016 |
Wei L, Li J, Yang X, Wang G, Feng B, Hou J, Duan Z, Jia J, Ren H, Niu J, Chen X, Wang FS, Shang J, Bo Q, Li R, et al. A nationwide survey of specialist knowledge on current standard of care (Peg-IFN/RBV) and barriers of care in chronic hepatitis C patients in China. Journal of Gastroenterology and Hepatology. PMID 27043040 DOI: 10.1111/Jgh.13399 |
0.553 |
|
| 2016 |
Wei L, Zhang M, Xu M, Chuang WL, Lu W, Xie W, Jia Z, Gong G, Li Y, Bae SH, Yang YF, Xie Q, Shumei L, Chen X, Niu J, et al. A phase 3, open-label study of daclatasvir plus asunaprevir in Asian patients with chronic hepatitis C virus genotype 1b infection who are ineligible for or intolerant to interferon alfa therapies with or without ribavirin. Journal of Gastroenterology and Hepatology. PMID 27003037 DOI: 10.1111/Jgh.13379 |
0.57 |
|
| 2016 |
Wang H, Xu H, Wang X, Wu R, Gao X, Jin Q, Niu J. Red Blood Cell Distribution Width to Platelet Ratio is Related to Histologic Severity of Primary Biliary Cirrhosis. Medicine. 95: e3114. PMID 26986159 DOI: 10.1097/Md.0000000000003114 |
0.436 |
|
| 2016 |
Han Z, Lv M, Shi Y, Yu J, Niu J, Yu XF, Zhang W. Mutation of Glycosylation Sites in BST-2 Leads to Its Accumulation at Intracellular CD63-Positive Vesicles without Affecting Its Antiviral Activity against Multivesicular Body-Targeted HIV-1 and Hepatitis B Virus. Viruses. 8. PMID 26938549 DOI: 10.3390/V8030062 |
0.452 |
|
| 2016 |
Pang X, Song H, Zhang Q, Tu Z, Niu J. Hepatitis C virus regulates the production of monocytic myeloid-derived suppressor cells from peripheral blood mononuclear cells through PI3K pathway and autocrine signaling. Clinical Immunology (Orlando, Fla.). PMID 26821305 DOI: 10.1016/J.Clim.2016.01.014 |
0.561 |
|
| 2016 |
Wu R, Chi X, Wang X, Sun H, Lv J, Gao X, Yu G, Kong F, Xu H, Hua R, Jiang J, Sun B, Zhong J, Pan Y, Niu J. IFNL4 ss469415590 polymorphism contributes to treatment decisions in patients with chronic hepatitis C virus genotype 1b, but not 2a, infection. Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases. PMID 26820907 DOI: 10.1016/J.Meegid.2016.01.020 |
0.54 |
|
| 2016 |
Yu G, Li H, Yang S, Wen J, Niu J, Zu Y. ssDNA Aptamer Specifically Targets and Selectively Delivers Cytotoxic Drug Doxorubicin to HepG2 Cells. Plos One. 11: e0147674. PMID 26808385 DOI: 10.1371/Journal.Pone.0147674 |
0.426 |
|
| 2016 |
Ding Y, Zhang H, Chen H, Li X, Liu C, Li Q, Niu J. Association of immune response parameters with virological response in hepatitis C virus patients treated with pegylated consensus interferon. International Journal of Clinical Pharmacology and Therapeutics. PMID 26754309 DOI: 10.5414/CP202439 |
0.544 |
|
| 2016 |
Mei R, Chi X, Wu R, Xu H, Wang X, Gao X, Sun H, Lv J, Yu G, Kong F, Jiang J, Sun B, Zhong J, Pan Y, Niu J. Sustained viral response and treatment-induced cytopenia correlate with SLCs and KLF12 genotypes in interferon/ribavirin-treated Chinese chronic hepatitis C patients. Journal of Gastroenterology and Hepatology. PMID 26750805 DOI: 10.1111/Jgh.13290 |
0.562 |
|
| 2016 |
Gao SQ, Niu JQ, Wang F, Liu XD, Jin ZX, Wang YL. [Comparative studies on the resistance of hepatitis B by Syringa extract, IFN and ganyanling in HepG2.2.15 cells]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi = Chinese Journal of Cellular and Molecular Immunology. 19: 385-6. PMID 15163392 |
0.473 |
|
| 2015 |
Zha YT, Liu GD, Zhou RD, Zhang XF, Niu JQ, Yu Y, Wang W. [EEMD-ICA Applied in Signal Extraction in Functional Near-Infrared Spectroscopy]. Guang Pu Xue Yu Guang Pu Fen Xi = Guang Pu. 35: 2746-51. PMID 26904811 |
0.353 |
|
| 2015 |
Rao H, Yang R, Shang J, Xu X, Chen X, Dou X, Feng Y, Gao Z, Xie Q, Li J, You H, Chen G, Niu J, Gong G, Hou J, et al. [The efficacy and prognostic predictors of different treatment courses with pegylated interferon α-2a and ribavirin combination in recurrent chronic hepatitis C patients]. Zhonghua Nei Ke Za Zhi. 54: 699-704. PMID 26674626 |
0.511 |
|
| 2015 |
Yang L, Zhang H, Jiang YF, Jin QL, Zhang P, Li X, Gao PJ, Niu JQ. Association of Estrogen Receptor Gene Polymorphisms and Primary Biliary Cirrhosis in a Chinese Population: A Case-Control Study. Chinese Medical Journal. 128: 3008-3014. PMID 26608979 DOI: 10.4103/0366-6999.168964 |
0.468 |
|
| 2015 |
Zeng J, Huang X, Zhou L, Tan Y, Hu C, Wang X, Niu J, Wang H, Lin X, Yin P. Metabolomics Identifies Biomarker Pattern for Early Diagnosis of Hepatocellular Carcinoma: from Diethylnitrosamine Treated Rats to Patients. Scientific Reports. 5: 16101. PMID 26526930 DOI: 10.1038/srep16101 |
0.426 |
|
| 2015 |
Pang X, Huang K, Zhang Q, Zhang Y, Niu J. miR-154 targeting ZEB2 in hepatocellular carcinoma functions as a potential tumor suppressor. Oncology Reports. PMID 26503460 DOI: 10.3892/Or.2015.4321 |
0.406 |
|
| 2015 |
Li H, Wei L, Jia J, Niu J, Rao H, Zheng Z. [Observational research is an important accompaniment to randomized and controlled clinical studies]. Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology. 23: 389-92. PMID 26427073 |
0.367 |
|
| 2015 |
Yu G, Chi X, Wu R, Wang X, Gao X, Kong F, Feng X, Gao Y, Huang X, Jin J, Qi Y, Tu Z, Sun B, Zhong J, Pan Y, ... Niu J, et al. Replication Inhibition of Hepatitis B Virus and Hepatitis C Virus in Co-Infected Patients in Chinese Population. Plos One. 10: e0139015. PMID 26422607 DOI: 10.1371/Journal.Pone.0139015 |
0.571 |
|
| 2015 |
Chen J, Wang N, Dong M, Guo M, Zhao Y, Zhuo Z, Zhang C, Chi X, Pan Y, Jiang J, Tang H, Niu J, Yang D, Li Z, Han X, et al. The metabolic regulator histone deacetylase 9 contributes to glucose homeostasis abnormality induced by hepatitis C virus infection. Diabetes. PMID 26420860 DOI: 10.2337/Db15-0197 |
0.525 |
|
| 2015 |
Xu H, Yu G, Sun H, Lv J, Wang M, Kong F, Zhang M, Chi X, Wang X, Wu R, Gao X, Zhong J, Sun B, Jiang J, Pan Y, ... Niu J, et al. Use of parenteral caffeinum natrio-benzoicum: an underestimated risk factor for HCV transmission in China. Bmc Public Health. 15: 928. PMID 26386815 DOI: 10.1186/S12889-015-2299-8 |
0.529 |
|
| 2015 |
Hou JL, Xu D, Shi G, Wan M, Goodman Z, Tan D, Xie Q, Chen C, Wei L, Niu J, Wang Q, Ren H, Wang Y, Jia J, Bao W, et al. Long-Term Telbivudine Treatment Results in Resolution of Liver Inflammation and Fibrosis in Patients with Chronic Hepatitis B. Advances in Therapy. 32: 727-41. PMID 26329749 DOI: 10.1007/S12325-015-0232-2 |
0.534 |
|
| 2015 |
Li W, Jiang Y, Wang X, Jin J, Qi Y, Chi X, Zhang H, Feng X, Niu J. Natural Killer p46 Controls Hepatitis B Virus Replication and Modulates Liver Inflammation. Plos One. 10: e0135874. PMID 26291078 DOI: 10.1371/Journal.Pone.0135874 |
0.504 |
|
| 2015 |
Wang Y, McGivern DR, Cheng L, Li G, Lemon SM, Niu J, Su L, Reszka-Blanco NJ. Ribavirin Contributes to Hepatitis C Virus Suppression by Augmenting pDC Activation and Type 1 IFN Production. Plos One. 10: e0135232. PMID 26274905 DOI: 10.1371/Journal.Pone.0135232 |
0.557 |
|
| 2015 |
Chen XY, Shang J, Yang RF, Xie Q, Gao ZL, Xu XY, Dou XG, Gong GZ, Chen GF, Li J, Chen H, Zhang DZ, Feng YN, Niu JQ, Hou JL, et al. [High sustained virological response to optimized therapy for refractory chronic hepatitis C treatment-na(i)ve patients: a multicenter randomized study]. Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology. 23: 412-417. PMID 26236925 DOI: 10.3760/Cma.J.Issn.1007-3418.2015.06.004 |
0.519 |
|
| 2015 |
Lv M, Zhang B, Shi Y, Han Z, Zhang Y, Zhou Y, Zhang W, Niu J, Yu XF. Identification of BST-2/tetherin-induced hepatitis B virus restriction and hepatocyte-specific BST-2 inactivation. Scientific Reports. 5: 11736. PMID 26119070 DOI: 10.1038/Srep11736 |
0.556 |
|
| 2015 |
Liu X, Chi X, Gong Q, Gao L, Niu Y, Chi X, Cheng M, Si Y, Wang M, Zhong J, Niu J, Yang W. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma. Plos One. 10: e0127518. PMID 25996938 DOI: 10.1371/Journal.Pone.0127518 |
0.531 |
|
| 2015 |
Sun H, Pan Y, Wu R, Lv J, Chi X, Wang X, Tu Z, Zhong J, Sun B, Liu Y, Jiang J, Niu J. CD24 Ala57Val polymorphism is associated with spontaneous viral clearance in the HCV-infected Chinese population. Liver International : Official Journal of the International Association For the Study of the Liver. 35: 786-94. PMID 25872416 DOI: 10.1111/Liv.12506 |
0.548 |
|
| 2015 |
Shi X, Chi X, Pan Y, Gao Y, Li W, Yang C, Zhong J, Xu D, Zhang M, Minuk G, Jiang J, Niu J. IL28B is associated with outcomes of chronic HBV infection. Yonsei Medical Journal. 56: 625-33. PMID 25837166 DOI: 10.3349/Ymj.2015.56.3.625 |
0.527 |
|
| 2015 |
Zhang P, Wang CY, Li YX, Pan Y, Niu JQ, He SM. Determination of the upper cut-off values of serum alanine aminotransferase and aspartate aminotransferase in Chinese. World Journal of Gastroenterology : Wjg. 21: 2419-24. PMID 25741150 DOI: 10.3748/Wjg.V21.I8.2419 |
0.408 |
|
| 2015 |
Zhao PW, Shi X, Li C, Ayana DA, Niu JQ, Feng JY, Wang J, Jiang YF. IL-33 Enhances Humoral Immunity Against Chronic HBV Infection Through Activating CD4(+)CXCR5(+) TFH Cells. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 35: 454-63. PMID 25714983 DOI: 10.1089/Jir.2013.0122 |
0.481 |
|
| 2015 |
Yang C, Zhao X, Sun D, Yang L, Chong C, Pan Y, Chi X, Gao Y, Wang M, Shi X, Sun H, Lv J, Gao Y, Zhong J, Niu J, et al. Interferon alpha (IFNα)-induced TRIM22 interrupts HCV replication by ubiquitinating NS5A. Cellular & Molecular Immunology. PMID 25683609 DOI: 10.1038/Cmi.2014.131 |
0.527 |
|
| 2015 |
Fan R, Sun J, Yuan Q, Xie Q, Bai X, Ning Q, Cheng J, Yu Y, Niu J, Shi G, Wang H, Tan D, Wan M, Chen S, Xu M, et al. Baseline quantitative hepatitis B core antibody titre alone strongly predicts HBeAg seroconversion across chronic hepatitis B patients treated with peginterferon or nucleos(t)ide analogues. Gut. PMID 25586058 DOI: 10.1136/Gutjnl-2014-308546 |
0.557 |
|
| 2015 |
Hou FQ, Song LW, Yuan Q, Fang LL, Ge SX, Zhang J, Sheng JF, Xie DY, Shang J, Wu SH, Sun YT, Wei SF, Wang MR, Wan MB, Jia JD, ... ... Niu JQ, et al. Quantitative hepatitis B core antibody level is a new predictor for treatment response in HBeAg-positive chronic hepatitis B patients receiving peginterferon. Theranostics. 5: 218-26. PMID 25553110 DOI: 10.7150/Thno.10636 |
0.507 |
|
| 2015 |
Cao X, Ding Q, Lu J, Tao W, Huang B, Zhao Y, Niu J, Liu YJ, Zhong J. MDA5 plays a critical role in interferon response during hepatitis C virus infection. Journal of Hepatology. 62: 771-8. PMID 25463548 DOI: 10.1016/J.Jhep.2014.11.007 |
0.552 |
|
| 2015 |
Liang X, Cheng J, Sun Y, Chen X, Li T, Wang H, Jiang J, Chen X, Long H, Tang H, Yu Y, Sheng J, Chen S, Niu J, Ren H, et al. Randomized, three-arm study to optimize lamivudine efficacy in hepatitis B e antigen-positive chronic hepatitis B patients. Journal of Gastroenterology and Hepatology. 30: 748-55. PMID 25352300 DOI: 10.1111/Jgh.12835 |
0.49 |
|
| 2015 |
Chen X, Niu J, Wang F, Liu W. [Measurement of anti-acetaldehyde protein adduct IgA, IgG, IgM antibody titers in the sera of human alcoholics]. Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology. 10: 350, 353. PMID 12392615 |
0.368 |
|
| 2015 |
Wang M, Wang F, Niu J. [The construction of HCV specific U1 small nuclear RNA chimeric ribozyme]. Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology. 10: 346. PMID 12392613 |
0.452 |
|
| 2014 |
Jia JD, Hou JL, Yin YK, Tan DM, Xu D, Niu JQ, Zhou XQ, Wang YM, Zhu LM, Chen CW, He YW, Ren H, Wan MB, Wu SM, Wang QH, et al. Two-year results of a randomized, phase III comparative trial of telbivudine versus lamivudine in Chinese patients. Hepatology International. 8: 72-82. PMID 26202408 DOI: 10.1007/S12072-013-9488-2 |
0.536 |
|
| 2014 |
Zou X, Chi X, Pan Y, Du D, Sun H, Matsuda A, Li W, Kuno A, Zhang X, Narimatsu H, Niu J, Zhang Y. LecT-Hepa facilitates estimating treatment outcome during interferon therapy in chronic hepatitis C patients. Clinical Proteomics. 11: 44. PMID 25593566 DOI: 10.1186/1559-0275-11-44 |
0.498 |
|
| 2014 |
Zhai N, Chi X, Li T, Song H, Li H, Jin X, Crispe IN, Su L, Niu J, Tu Z. Hepatitis C virus core protein triggers expansion and activation of CD4(+)CD25(+) regulatory T cells in chronic hepatitis C patients. Cellular & Molecular Immunology. PMID 25531392 DOI: 10.1038/Cmi.2014.119 |
0.485 |
|
| 2014 |
Chen J, Zhao Y, Zhang C, Chen H, Feng J, Chi X, Pan Y, Du J, Guo M, Cao H, Chen H, Wang Z, Pei R, Wang Q, Pan L, ... Niu J, et al. Persistent hepatitis C virus infections and hepatopathological manifestations in immune-competent humanized mice. Cell Research. 24: 1050-66. PMID 25155355 DOI: 10.1038/Cr.2014.116 |
0.541 |
|
| 2014 |
Kong F, Pan Y, Chi X, Wang X, Chen L, Lv J, Sun H, Wu R, Jin J, Yu G, Ma Z, Wang Y, Huang X, Li H, Bai Y, ... ... Niu J, et al. Factors associated with spontaneous clearance of hepatitis C virus in Chinese population. Biomed Research International. 2014: 527030. PMID 25133165 DOI: 10.1155/2014/527030 |
0.55 |
|
| 2014 |
Tian S, Chang HH, Wang C, Jiang J, Wang X, Niu J. Multi-TGDR, a multi-class regularization method, identifies the metabolic profiles of hepatocellular carcinoma and cirrhosis infected with hepatitis B or hepatitis C virus. Bmc Bioinformatics. 15: 97. PMID 24707821 DOI: 10.1186/1471-2105-15-97 |
0.509 |
|
| 2014 |
Bility MT, Cheng L, Zhang Z, Luan Y, Li F, Chi L, Zhang L, Tu Z, Gao Y, Fu Y, Niu J, Wang F, Su L. Hepatitis B virus infection and immunopathogenesis in a humanized mouse model: induction of human-specific liver fibrosis and M2-like macrophages. Plos Pathogens. 10: e1004032. PMID 24651854 DOI: 10.1371/Journal.Ppat.1004032 |
0.54 |
|
| 2014 |
Liu F, You X, Chi X, Wang T, Ye L, Niu J, Zhang X. Hepatitis B virus X protein mutant HBxΔ127 promotes proliferation of hepatoma cells through up-regulating miR-215 targeting PTPRT. Biochemical and Biophysical Research Communications. 444: 128-34. PMID 24434140 DOI: 10.1016/j.bbrc.2014.01.004 |
0.435 |
|
| 2014 |
Chen W, Xu Y, Li H, Tao W, Xiang Y, Huang B, Niu J, Zhong J, Meng G. HCV genomic RNA activates the NLRP3 inflammasome in human myeloid cells. Plos One. 9: e84953. PMID 24400125 DOI: 10.1371/Journal.Pone.0084953 |
0.522 |
|
| 2014 |
Sun J, Xie Q, Tan D, Ning Q, Niu J, Bai X, Fan R, Chen S, Cheng J, Yu Y, Wang H, Xu M, Shi G, Wan M, Chen X, et al. The 104-week efficacy and safety of telbivudine-based optimization strategy in chronic hepatitis B patients: a randomized, controlled study. Hepatology (Baltimore, Md.). 59: 1283-92. PMID 24382690 DOI: 10.1002/Hep.26885 |
0.509 |
|
| 2014 |
Hu X, Jiang Y, Li X, Gao Y, Guo X, Chi X, Yan H, Feng J, Zhong J, Sun B, Shao X, Xiao W, Pan Y, Niu J. Long-term effect on natural killer cells by interferon-α therapy on the outcomes of HCV infection. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 34: 366-75. PMID 24367931 DOI: 10.1089/jir.2013.0049 |
0.521 |
|
| 2014 |
Rao H, Wei L, Lopez-Talavera JC, Shang J, Chen H, Li J, Xie Q, Gao Z, Wang L, Wei J, Jiang J, Sun Y, Yang R, Li H, Zhang H, ... ... Niu J, et al. Distribution and clinical correlates of viral and host genotypes in Chinese patients with chronic hepatitis C virus infection. Journal of Gastroenterology and Hepatology. 29: 545-53. PMID 24090188 DOI: 10.1111/Jgh.12398 |
0.557 |
|
| 2013 |
Chen L, Lv J, Wen X, Niu J. CXC chemokine IP-10: a key actor in liver disease? Hepatology International. 7: 798-804. PMID 26201916 DOI: 10.1007/S12072-013-9445-0 |
0.547 |
|
| 2013 |
Sun H, Lv J, Tu Z, Hu X, Yan H, Pan Y, Xu D, Lian Z, Chi X, Niu J. Antiviral treatment improves disrupted peripheral B lymphocyte homeostasis in chronic hepatitis B virus-infected patients. Experimental Biology and Medicine (Maywood, N.J.). 238: 1275-83. PMID 24085784 DOI: 10.1177/1535370213502626 |
0.501 |
|
| 2013 |
Zhang M, Wu R, Jiang J, Minuk GY, Niu J. The presence of hepatitis B core antibody is associated with more advanced liver disease in alcoholic patients with cirrhosis. Alcohol (Fayetteville, N.Y.). 47: 553-8. PMID 24041840 DOI: 10.1016/J.Alcohol.2013.07.003 |
0.55 |
|
| 2013 |
Qi Y, Xiang Y, Wang J, Qi Y, Li J, Niu J, Zhong J. Inhibition of hepatitis C virus infection by polyoxometalates. Antiviral Research. 100: 392-8. PMID 24025401 DOI: 10.1016/J.Antiviral.2013.08.025 |
0.535 |
|
| 2013 |
Tu Z, Zhang P, Li H, Niu J, Jin X, Su L. Cross-linking of CD81 by HCV-E2 protein inhibits human intrahepatic plasmacytoid dendritic cells response to CpG-ODN. Cellular Immunology. 284: 98-103. PMID 23954883 DOI: 10.1016/J.Cellimm.2013.07.012 |
0.496 |
|
| 2013 |
Ji HF, Wang J, Yu L, Niu JQ, Ayana DA, Jiang YF. High frequencies of CD158b+ NK cells are associated with persistent hepatitis C virus infections. Annals of Hepatology. 12: 539-47. PMID 23813131 |
0.556 |
|
| 2013 |
Ding Y, Zhang H, Li Y, Wu D, He S, Wang Y, Li Y, Wang F, Niu J. Inhibition of HCV 5'-NTR and core expression by a small hairpin RNA delivered by a histone gene carrier, HPhA. International Journal of Medical Sciences. 10: 957-64. PMID 23801881 DOI: 10.7150/ijms.5632 |
0.483 |
|
| 2013 |
Zhao PW, Jia FY, Shan YX, Ji HF, Feng JY, Niu JQ, Ayana DA, Jiang YF. Downregulation and altered function of natural killer cells in hepatitis B virus patients treated with entecavir. Clinical and Experimental Pharmacology & Physiology. 40: 190-6. PMID 23278368 DOI: 10.1111/1440-1681.12048 |
0.538 |
|
| 2013 |
Ma L, Cai Y, Yu L, Feng J, Wang J, Li C, Niu J, Jiang Y. Treatment with Telbivudine positively regulates antiviral immune profiles in Chinese patients with chronic hepatitis B Antimicrobial Agents and Chemotherapy. 57: 1304-1311. PMID 23274669 DOI: 10.1128/Aac.02181-12 |
0.461 |
|
| 2012 |
Lv J, Jin Q, Sun H, Chi X, Hu X, Yan H, Pan Y, Xiao W, Tian Z, Hou J, Xu D, Tu Z, Niu J. Antiviral treatment alters the frequency of activating and inhibitory receptor-expressing natural killer cells in chronic hepatitis B virus infected patients. Mediators of Inflammation. 2012: 804043. PMID 23304062 DOI: 10.1155/2012/804043 |
0.498 |
|
| 2012 |
Niu LL, Niu JQ. [Recent development of the application of metabolomics in liver diseases]. Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology. 20: 634-5. PMID 23227536 |
0.452 |
|
| 2012 |
Jia Z, Ding Y, Tian S, Niu J, Jiang J. Test of IL28B polymorphisms in chronic hepatitis C patients treated with PegIFN and ribavirin depends on HCV genotypes: results from a meta-analysis. Plos One. 7: e45698. PMID 23029188 DOI: 10.1371/journal.pone.0045698 |
0.527 |
|
| 2012 |
Zhou L, Ding L, Yin P, Lu X, Wang X, Niu J, Gao P, Xu G. Serum metabolic profiling study of hepatocellular carcinoma infected with hepatitis B or hepatitis C virus by using liquid chromatography-mass spectrometry. Journal of Proteome Research. 11: 5433-42. PMID 22946841 DOI: 10.1021/pr300683a |
0.566 |
|
| 2012 |
Shi X, Pan Y, Wang M, Wang D, Li W, Jiang T, Zhang P, Chi X, Jiang Y, Gao Y, Zhong J, Sun B, Xu D, Jiang J, Niu J. IL28B genetic variation is associated with spontaneous clearance of hepatitis C virus, treatment response, serum IL-28B levels in Chinese population. Plos One. 7: e37054. PMID 22649509 DOI: 10.1371/Journal.Pone.0037054 |
0.557 |
|
| 2012 |
Hu X, Chen H, Jin M, Wang X, Lee J, Xu W, Zhang R, Li S, Niu J. Molecular cytogenetic characterization of undifferentiated embryonal sarcoma of the liver: a case report and literature review. Molecular Cytogenetics. 5: 26. PMID 22551002 DOI: 10.1186/1755-8166-5-26 |
0.409 |
|
| 2012 |
Wang X, Zhu C, Bao W, Zhao K, Niu J, Yu XF, Zhang W. Characterization of full-length enterovirus 71 strains from severe and mild disease patients in northeastern China. Plos One. 7: e32405. PMID 22479324 DOI: 10.1371/Journal.Pone.0032405 |
0.419 |
|
| 2012 |
Feng J, Hu X, Guo H, Sun X, Wang J, Xu L, Jiang Z, Xu B, Niu J, Jiang Y. Patients with chronic hepatitis C express a high percentage of CD4(+)CXCR5(+) T follicular helper cells. Journal of Gastroenterology. 47: 1048-56. PMID 22426636 DOI: 10.1007/S00535-012-0568-1 |
0.494 |
|
| 2012 |
Wang J, Zhao P, Guo H, Sun X, Jiang Z, Xu L, Feng J, Niu J, Jiang Y. Serum IL-33 levels are associated with liver damage in patients with chronic hepatitis C. Mediators of Inflammation. 2012: 819636. PMID 22315510 DOI: 10.1155/2012/819636 |
0.479 |
|
| 2012 |
Wang J, Cai Y, Ji H, Feng J, Ayana DA, Niu J, Jiang Y. Serum IL-33 levels are associated with liver damage in patients with chronic hepatitis B. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 32: 248-53. PMID 22304300 DOI: 10.1089/Jir.2011.0109 |
0.423 |
|
| 2012 |
Zhang H, Qi Y, Ding Y, Wang J, Li Q, Zhang J, Jiang Y, Chi X, Li J, Niu J. Synthesis, characterization and biological activity of a niobium-substituted-heteropolytungstate on hepatitis B virus. Bioorganic & Medicinal Chemistry Letters. 22: 1664-9. PMID 22264474 DOI: 10.1016/J.Bmcl.2011.12.115 |
0.527 |
|
| 2012 |
Jin Q, Moritoki Y, Lleo A, Tsuneyama K, Invernizzi P, Moritoki H, Kikuchi K, Lian ZX, Hirschfield GM, Ansari AA, Coppel RL, Gershwin ME, Niu J. Comparative analysis of portal cell infiltrates in antimitochondrial autoantibody-positive versus antimitochondrial autoantibody-negative primary biliary cirrhosis. Hepatology (Baltimore, Md.). 55: 1495-506. PMID 22135136 DOI: 10.1002/Hep.25511 |
0.459 |
|
| 2012 |
Qi YF, Zhang H, Wang J, Jiang Y, Li J, Yuan Y, Zhang S, Xu K, Li Y, Li J, Niu J, Wang E. In vitro anti-hepatitis B and SARS virus activities of a titanium-substituted-heteropolytungstate. Antiviral Research. 93: 118-25. PMID 22127069 DOI: 10.1016/J.Antiviral.2011.11.003 |
0.489 |
|
| 2012 |
Piao RL, Liu YY, Tian D, Ma ZH, Zhang M, Zhao C, Niu JQ. Adefovir dipivoxil modulates cytokine expression in Th1/Th2 cells in patients with chronic hepatitis B. Molecular Medicine Reports. 5: 184-9. PMID 21993835 DOI: 10.3892/mmr.2011.627 |
0.51 |
|
| 2011 |
He S, Bao W, Shao M, Wang W, Wang C, Sun J, Jiang Y, Feng X, Niu J. Risk factors for non-alcoholic fatty liver disease in a Chinese population. Acta Gastro-Enterologica Belgica. 74: 503-8. PMID 22319959 |
0.453 |
|
| 2011 |
Jin J, Niu J, Kim YM, Wang X, Parham D, Letton R, Li S, Lee JY. A novel t(8;13)(q21;q22) translocation in a pediatric lipoma. Cancer Genetics. 204: 629-33. PMID 22200087 DOI: 10.1016/j.cancergen.2011.10.010 |
0.345 |
|
| 2011 |
Zhang H, Jiang YF, He SM, Sun J, Gu Q, Feng XW, DU B, Wang W, Shi XD, Wang CY, Zhang SQ, Li WY, Niu JQ. Etiology and prevalence of abnormal serum alanine aminotransferase levels in a general population in Northeast China. Chinese Medical Journal. 124: 2661-8. PMID 22040420 |
0.475 |
|
| 2011 |
Li W, Jiang Y, Jin Q, Shi X, Jin J, Gao Y, Pan Y, Zhang H, Jiang J, Niu J. Expression and gene polymorphisms of interleukin 28B and hepatitis B virus infection in a Chinese Han population. Liver International : Official Journal of the International Association For the Study of the Liver. 31: 1118-26. PMID 21745278 DOI: 10.1111/J.1478-3231.2011.02507.X |
0.557 |
|
| 2011 |
Zhang H, Li Q, Sun J, Wang C, Gu Q, Feng X, Du B, Wang W, Shi X, Zhang S, Li W, Jiang Y, Feng J, He S, Niu J. Seroprevalence and risk factors for hepatitis B infection in an adult population in Northeast China. International Journal of Medical Sciences. 8: 321-31. PMID 21611114 |
0.53 |
|
| 2011 |
Gane EJ, Wang Y, Liaw YF, Hou J, Thongsawat S, Wan M, Moon YM, Jia J, Chao YC, Niu J, Leung N, Samuel D, Hsu CW, Bao W, Lopez P, et al. Efficacy and safety of prolonged 3-year telbivudine treatment in patients with chronic hepatitis B. Liver International : Official Journal of the International Association For the Study of the Liver. 31: 676-84. PMID 21457439 DOI: 10.1111/J.1478-3231.2011.02490.X |
0.54 |
|
| 2010 |
Jiang Y, Ma Z, Xin G, Yan H, Li W, Xu H, Hao C, Niu J, Zhao P. Th1 and Th2 immune response in chronic hepatitis B patients during a long-term treatment with adefovir dipivoxil. Mediators of Inflammation. 2010: 143026. PMID 21127728 DOI: 10.1155/2010/143026 |
0.512 |
|
| 2010 |
Jiang Y, Li W, Yu L, Liu J, Xin G, Yan H, Sun P, Zhang H, Xu D, Niu J. Enhancing the antihepatitis B virus immune response by adefovir dipivoxil and entecavir therapies. Cellular & Molecular Immunology. 8: 75-82. PMID 20921939 DOI: 10.1038/Cmi.2010.37 |
0.541 |
|
| 2010 |
Li WY, Jiang YF, Jin QL, Zhang H, Feng XW, Niu JQ. Immunologic characterization of posthepatitis cirrhosis caused by HBV and HCV infection. Journal of Biomedicine & Biotechnology. 2010: 138237. PMID 20617133 DOI: 10.1155/2010/138237 |
0.54 |
|
| 2010 |
Gao JW, Li YJ, Zhuang H, Li J, Wang J, Dong QM, Chen YJ, Niu JQ, Ma WM, Zhao W, Zhao BA, Zhong JQ. [Distribution of hepatitis B virus genotypes in patients with chronic hepatitis B virus infection among 12 cities in China]. Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi. 28: 315-8. PMID 17850692 |
0.577 |
|
| 2010 |
Jiang YF, Zhao PW, Tan Y, Liu LH, Li MH, Matsuzaki Y, Niu JQ. [Molecular mechanisms of DHEA and DHEAs on apoptosis and cell cycle arrest via Akt pathway in hepatoma cell lines]. Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology. 15: 441-4. PMID 17594810 |
0.385 |
|
| 2010 |
Wang Y, Niu JQ, Ding YH, Wang F. [Inhibition of HBV replication and expression by RNAi]. Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology. 14: 790-2. PMID 17064484 |
0.476 |
|
| 2010 |
Li J, Pan Y, Bao WG, Niu JQ, Wang F. [Multistix10SG urine test in diagnosing spontaneous bacterial peritonitis]. Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology. 14: 784-5. PMID 17064481 |
0.35 |
|
| 2009 |
Jiang YF, Zhao PW, Qin JJ, Li MH, Yasushi M, Niu JQ. [The effect of DHEA on AKT signal pathway on transplanted Morris hepatomas in rats]. Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology. 17: 679-82. PMID 19785956 |
0.358 |
|
| 2009 |
Liu Y, Wang H, Du N, Shen E, Chen H, Niu J, Ye H, Chen M. Molecular evidence for spread of two major methicillin-resistant Staphylococcus aureus clones with a unique geographic distribution in Chinese hospitals. Antimicrobial Agents and Chemotherapy. 53: 512-8. PMID 19029328 DOI: 10.1128/AAC.00804-08 |
0.366 |
|
| 2008 |
Liaw YF, Gane E, Leung N, Zeuzem S, Wang Y, Lai CL, Heathcote EJ, Manns M, Bzowej N, Niu J, Han SH, Hwang SG, Cakaloglu Y, Tong MJ, Papatheodoridis G, et al. 2-Year GLOBE trial results: telbivudine Is superior to lamivudine in patients with chronic hepatitis B. Gastroenterology. 136: 486-95. PMID 19027013 DOI: 10.1053/J.Gastro.2008.10.026 |
0.535 |
|
| 2008 |
Xu DZ, Zhao K, Guo LM, Chen XY, Wang HF, Zhang JM, Xie Q, Ren H, Wang WX, Li LJ, Xu M, Liu P, Niu JQ, Bai XF, Shen XL, et al. A randomized controlled phase IIb trial of antigen-antibody immunogenic complex therapeutic vaccine in chronic hepatitis B patients Plos One. 3. PMID 18596958 DOI: 10.1371/Journal.Pone.0002565 |
0.507 |
|
| 2008 |
Zhang KY, Niu JQ. Hepatorenal syndrome: current diagnostic and therapeutic concepts Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology. 16: 410-411. PMID 18578988 |
0.355 |
|
| 2008 |
Hou J, Yin YK, Xu D, Tan D, Niu J, Zhou X, Wang Y, Zhu L, He Y, Ren H, Wan M, Chen C, Wu S, Chen Y, Xu J, et al. Telbivudine versus lamivudine in Chinese patients with chronic hepatitis B: Results at 1 year of a randomized, double-blind trial. Hepatology (Baltimore, Md.). 47: 447-54. PMID 18080339 DOI: 10.1002/Hep.22075 |
0.563 |
|
| 2007 |
Chan HL, Wang H, Niu J, Chim AM, Sung JJ. Two-year lamivudine treatment for hepatitis B e antigen-negative chronic hepatitis B: a double-blind, placebo-controlled trial. Antiviral Therapy. 12: 345-53. PMID 17591024 |
0.54 |
|
| 2007 |
Jia JD, Hou JL, Yin YK, Xu DZ, Tan DM, Niu JQ, Zhou XQ, Wang YM, Zhu LM, He YW, Ren H, Wan MB, Chen CW, Wu SM, Chen YG, et al. [The degree of HBV suppression with 24 week telbivudine- or lamivudine-treatment in hepatitis B patients predicts the efficacy of the treatment at week 52]. Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology. 15: 342-5. PMID 17524265 |
0.534 |
|
| 2007 |
Zhao H, Kurbanov F, Wan MB, Yin YK, Niu JQ, Hou JL, Wei L, Wang GQ, Tanaka Y, Mizokami M, Si CW. Genotype B and younger patient age associated with better response to low-dose therapy: a trial with pegylated/nonpegylated interferon-alpha-2b for hepatitis B e antigen-positive patients with chronic hepatitis B in China. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 44: 541-8. PMID 17243057 DOI: 10.1086/511042 |
0.566 |
|
| 2007 |
Wen XY, Bao WG, Yang XY, Tian MM, Wang F, Niu JQ. [Cleavage of HCV by HCV specific deoxyribozyme in vitro]. Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology. 13: 900-2. PMID 16381634 |
0.53 |
|
| 2007 |
Ren N, Wang F, Niu JQ. [A study of 10-23 DNAzyme inhibiting the expression of hepatitis B virus genes]. Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology. 13: 745-8. PMID 16248946 |
0.553 |
|
| 2007 |
Li YJ, Zhuang H, Li J, Dong QM, Chen YJ, Niu JQ, Ma WM, Zhao W, Zhao BA, Zhong JQ. [Distribution and clinical significance of hepatitis B virus (HBV) genotypes and subtypes in HBV-infected patients]. Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology. 13: 724-9. PMID 16248941 |
0.571 |
|
| 2006 |
Zhao H, Si CW, Wei L, Wan MB, Ying YK, Hou JL, Niu JQ. [A multicenter, randomized, open-label study of the safety and effectiveness of pegylated interferon alpha 2b and interferon alpha 2b in treating HBeAg positive chronic hepatitis B patients]. Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology. 14: 323-6. PMID 16732903 |
0.505 |
|
| 2006 |
Wang MX, Jin QL, Pan Y, Wang F, Niu JQ. [Inhibition of HCV replication by HCV specific U1 small nuclear RNA chimeric ribozyme in vivo]. Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology. 14: 11-4. PMID 16420757 |
0.473 |
|
| 2004 |
Tian MM, Wang F, Niu JQ, Wang MX. [Study on the cleavage activity of U1 small nuclear RNA chimeric ribozyme against HCV RNA in vitro]. Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology. 12: 749-51. PMID 15619345 |
0.449 |
|
| 2004 |
Piao YF, Tang TY, Niu JQ, Wang F. Construction of eukaryotic expression plasmids of hepatitis B surface antigen and helper T lymphocyte epitope. Hepatobiliary & Pancreatic Diseases International : Hbpd Int. 3: 219-22. PMID 15138113 |
0.503 |
|
| Show low-probability matches. |